DEVELOPMENT OF MICROFLUIDIC PLATFORMS AS A TOOL FOR HIGH-THROUGHPUT BIOMARKER SCREENING by Zec, Helena
  
 
DEVELOPMENT OF MICROFLUIDIC 
PLATFORMS AS A TOOL FOR HIGH-











A dissertation submitted to The Johns Hopkins University in conformity with the 













© 2015 Helena Zec 






Droplet microfluidic platforms are in the early stages of revolutionizing high throughput 
and combinatorial sample screening for bioanalytical applications. However, many 
droplet platforms are incapable of addressing the needs of numerous applications, which 
require high degrees of multiplexing, as well as high-throughput analysis of multiple 
samples. Examples of applications include single nucleotide polymorphism (SNP) 
analysis for crop improvement and genotyping for the identification of genes associated 
with common diseases. My PhD thesis focused on developing microfluidic devices to 
extend their capabilities to meet the needs of a wide array of applications.  
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Microfluidic systems refer to enclosed networks of channels in which fluid is 
manipulated in a confined geometry where at least one of the dimensions is below 1 mm. 
In droplet microfluidics, thousands of discrete reaction chambers are generated in the 
form of droplet emulsions. In these systems, each individual droplet is separated by an 
immiscible carrier phase (typically oil or gas). At present, there are several different 
methods for generating droplets in a high-throughput fashion. In these miniaturized 
systems, droplet volumes typically fall within picoliter to nanoliter range. Reducing 
reaction volumes by several orders of magnitude significantly lowers the costs of 
reagents. Furthermore, millions of droplets can be generated and analyzed on a single 
device, thus improving the accuracy of statistical analysis. In addition, reaction kinetics 
in droplets are favorable due to improved surface-to-volume ratios (compared with bulk 
methods). Additional advantages are that carrier fluid shields each droplet, mitigating the 
problems of absorption onto solid surfaces and contamination. Droplet microfluidics has 
the potential to satisfy the unmet needs for increased miniaturization, scalability and 
automation in biosample analysis.  
Droplet-based microfluidic systems have a special advantage over other emulsion-
generating techniques in that highly monodisperse droplets are generated. Droplets 
generated with bulk-created emulsions, are limited in applications due to the lack of 
control over droplet sizes. This size polydispersity limits the ability to perform 
quantitative measurements. In contrast, generating droplets in microfluidic systems has 
the advantage of creating monodisperse sample volumes that improves reaction 
conditions.  
On the other hand, two key limitations of most droplet based devices include the 
difficulty of manipulating droplets after formation and measuring reaction kinetics within 
individual droplets in real time. Operations required for performing chemical reactions in 
droplets include droplet fusion, droplet fission, and droplet sorting. Automated 
manipulation of droplets in microchannels, combined with the ability to perform 
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biochemical reactions inside microdroplets, has inspired the development of versatile 
platforms for numerous applications ranging from molecular diagnostics to organic 
synthesis. In these devices, each individual droplet functions as a miniaturized reaction 
container. This approach allows the controlled manipulation of small volumes of reaction 
mixtures and permits the rapid partitioning of single molecules from complex samples 
that facilitates digital analysis. Interested readers are referred to comprehensive reviews 
of droplet-based microfluidic systems that review various operations that can be 
performed with these systems and their applications.  
The ability to generate monodisperse droplets at extremely high throughput (kHz 
frequencies) facilitates experiments previously rendered impossible due to the practical 
constraint on the number of reactions that can be performed using traditional bench-top 
technologies. In this thesis, we will overcome some of the limitations of droplet 
microfluidic tehnology. 
 
1.1 Thesis overview 
 
The overall goal of this thesis was to investigate the use of droplet microfluidic 
devices to extend their use in bioanalysis applications.  
An overview of droplet platforms is presented in Chapter 2. Chapter 3 discusses the 
development of a microfluidic platform which can perform combinatorial screening 
operations. In Chapter 4, I describe a platform to increase the throughput of this 
combinatorial screening microfluidic device.  Chapter 5 demonstrates an application of 
our microfluidic device in the agricultural industry. Chapter 6 investigates the use of a 
microfluidic device for digital analysis of DNA molecules in cancer. The thesis will 
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Personalized medicine – healthcare based on individual genetic variation – has the 
potential to transform the way healthcare is delivered to patients. The promise of 
personalized medicine has been predicated on the predictive and diagnostic power of 
genomic and proteomic biomarkers. Biomarker screening may help improve health 
outcomes, for example, by identifying individuals’ susceptibility to diseases and 
predicting how patients will respond to drugs. Microfluidic droplet technology offers an 
exciting opportunity to revolutionize the accessibility of personalized medicine. A 
framework for the role of droplet microfluidics in biomarker detection can be based on 
two main themes. Emulsion-based microdroplet platforms can provide new ways to 
measure and detect biomolecules. In addition, microdroplet platforms facilitate high-
throughput screening of biomarkers. Meanwhile, surface-based droplet platforms provide 
an opportunity to develop miniaturized diagnostic systems. These platforms may function 
as portable benchtop environments that dramatically shorten the transition of a benchtop 
assay into a point-of-care format. 
 
2.1 Biomarkers in diagnostics 
 
Biomarker profiling assays are based on patterns of molecules such as nucleic acids, 
proteins and metabolites. The clinical applications of biomarker profiling run the gamut: 
4 
 
from examining normal biological processes, to monitoring pathogenic processes or 
pharmacological responses to a therapeutic intervention [1]. Segmenting patient 
populations based on biomarkers may facilitate clinical interventions. As clinical 
sequencing gains traction, there has been increased interest to connect genotype to 
phenotype. For example, sequencing has been used to correlate rare mutations to 
previously unidentified disorders [2]. However, several challenges remain. One major 
challenge is disease heterogeneity [3]. For instance, cancer is a heterogeneous disease 
characterized by a spectrum of genetic and epigenetic alterations [4]. In heterogeneous 
diseases like cancer, the use of genetic mutations as biomarkers necessitates sensitive 
strategies that allow detection of mutations within a milieu of predominantly wild-type 
DNA molecules [5]. Bulk procedures measure ensemble signals (Fig. 1), which have a 
very low sensitivity for rare sequences within biological samples. The ability to detect 
extremely rare populations of nucleic acids from a background of normal targets has the 
potential to transform clinical medicine. In light of this, technologies enabling 
digitization of biochemical assays are highly desirable. In addition to resolving genetic 
heterogeneity in disease, patterns of molecular heterogeneity on the single-cell level may 
be explored to determine the role in disease pathology and cellular responses to 
treatment. Molecular biomarker profiling also facilitates new paradigms for patient 
diagnostics and treatment in a manner that is more rapid and robust, such that efficacious 
therapeutic intervention can be achieved with minimal delay after diagnosis. In the case 
of infectious diseases, early diagnostics and treatment may help interrupt transmission of 
infectious agents and carry an additional importance from a public health standpoint [6]. 
While infectious agents have traditionally relied on culture-based assessment to identify 
the pathogen and determine the appropriate antibiotic treatment, the requirement of 
facilities and trained personnel as well as the time and cost of microbial culture limits the 
accessibility and efficacy of these assays. The emergence of PCR-based techniques for 
pathogen detection enables highly sensitive assays that can be performed with a 
significant reduction in cost and turnaround time [7]. In addition, genetic polymorphisms 
that have shown clear associations with patient response to therapeutic agents may help 
improve the efficacy of clinical interventions. One important example is patient 
sensitivity to the anticoagulant warfarin, which is known to be substantially less effective 
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in patients with mutations in the VKORC1 gene [8] and may be tested using PCR-based 
techniques for polymorphism identification. As these diagnostic assays can provide 
immediately useful information to the practicing clinician, there is a strong motivation to 
develop technologies in order to deliver these tests outside centralized laboratories. This 
review will demonstrate how miniaturized droplet technologies will facilitate biomarker 
analysis by allowing the sensitive detection and quantification of biomolecules. Instead of 
assays targeting single biomarkers to confer a diagnosis, highthroughput screening 
technologies allow screening of panels of biomarkers to elucidate patterns in diseases. 
The importance of testing a panel of biomarkers is particularly relevant to heterogeneous 
diseases like cancer and complex diseases like chronic inflammation. In addition to 
reviewing the role of droplet-based microfluidic devices in high-throughput screening 
applications, we will explore how surface-based miniaturized droplet platforms can be 
utilized to miniaturize an entire bench-top assay in a portable format. Finally, we will 
review miniaturized array-based technologies and their applications in biomarker 
discovery and detection. For the interested reader, there are several reviews that have 
recently explored the role of continuous flow microfluidic platforms on biomarker 
analysis [9, 10]. 
 
2.2 Types of droplet platforms  
2.2.1 Microfluidic droplet platforms 
Microfluidic systems refer to enclosed networks of channels (Fig. 2) in which fluid is 
manipulated in a confined geometry where at least one of the dimensions is below 1 mm. 
In droplet microfluidics, thousands of discrete reaction chambers are generated in the 
form of droplet emulsions. In these systems, each individual droplet is separated by an 
immiscible carrier phase (typically oil or gas). Droplet-based microfluidic systems have a 
special advantage over other emulsion-generating techniques in that highly monodisperse 
droplets are generated. Furthermore, droplets can be generated and manipulated at kHz 
frequencies in microfluidic systems. At present, there are several different methods for 
generating droplets in a high-throughput fashion. In these miniaturized systems, droplet 
volumes typically fall within picoliter to nanoliter range. Reducing reaction volumes by 
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several orders of magnitude significantly lowers the costs of reagents. Furthermore, 
millions of droplets can be generated and analyzed on a single device, thus improving the 
accuracy of statistical analysis. In addition, reaction kinetics in droplets are favorable due 
to improved surface-to-volume ratios (compared with bulk methods). On the other hand, 
two key limitations of most droplet based devices include the difficulty of manipulating 
droplets after formation and measuring reaction kinetics within individual droplets in real 
time. Automated manipulation of droplets in microchannels, combined with the ability to 
perform biochemical reactions inside microdroplets, has inspired the development of 
versatile platforms for numerous applications ranging from molecular diagnostics to 
organic synthesis. In these devices, each individual droplet functions as a miniaturized 
reaction container. This approach allows the controlled manipulation of small volumes of 
reaction mixtures and permits the rapid partitioning of single molecules from complex 
samples that facilitates digital analysis. Interested readers are referred to comprehensive 
reviews of droplet-based microfluidic systems that review various operations that can be 
performed with these systems and their applications [11-19]. The ability to generate 
monodisperse droplets at extremely high throughput (kHz frequencies) facilitates 
experiments previously rendered impossible due to the practical constraint on the number 
of reactions that can be performed using traditional bench-top technologies.  
 
2.2.2 Surface droplet platforms  
 
Surface droplet manipulation is a branch of techniques that has evolved outside the 
channel-based microemulsion paradigm. In this approach, aqueous reservoirs in the 
nanoliter-to-microliter range are manipulated individually on an open planar substrate 
rather than inside microchannels (Fig. 2). Surface droplet platforms focus on scalable 
fluidic processing mechanisms that do not require to be pressure-driven. Departure from 
pumps and complex fluidic architecture also lends these platforms to applications in 
point-of-care diagnostics and mobile medicine. Various modes of actuation (Fig. 3) have 
been explored for surface droplet manipulation, including electric [20-29], 
magnetofluidic [26, 30-41], acoustic [42-45], optical [46] and pneumatic actuation [47]. 
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Among these, electric and magnetic actuation have received the most attention due to 
their advantages in speed, robust operating principles as well as compatibility with 
biochemical assays. Electrical actuation of droplets is an attractive concept, in part 
because the transition to electrical rather than mechanical actuators opens up the potential 
to leverage recent advancements in consumer electronics. While mechanisms such as 
droplet dielectrophoresis [20-22] and electrophoresis [28] have been explored to varying 
degrees, electrowetting-on-dielectric (EWOD) has gained the most attention due to the 
flexibility in device layout and wide range of fluidic operations that can be realized. The 
main principle of EWOD operation relies on the phenomenon of electrowetting, where 
the interfacial tension between the liquid droplet and solid substrate is altered when 
electric field is applied directly across the droplet. In the typical two-layer arrangement as 
shown in Fig. 3, an electrolyte solution is sandwiched between a reference electrode and 
a control electrode covered by a dielectric surface. When a voltage is applied across an 
electrolyte, this induces accumulation of charge along the electrolyte–dielectric interface 
and subsequent spreading of the liquid along the dielectric surface within the confines of 
the control electrode. In a typical EWOD device, an array of square electrode tiles is 
patterned on one substrate in order to facilitate actuation of a droplet on a surface at a 
resolution of one electrode tile. This mechanism forms the basis of all operations, 
including transport, mixing and fission of droplets, and has [31] been demonstrated in 
processes involving multiple fluid handling operations including nucleic acid extraction 
[25] and pyrosequencing [26]. Magnetofluidic actuation is another approach that has 
demonstrated its capacity for handling a diverse range of biochemical assays. A typical 
arrangement of magnetofluidic actuation involves aqueous droplets containing a 
suspension of magnetic particles and relies on the use of magnetic force and energy 
barriers to achieve the desired manipulation process. As shown in Fig. 3, magnetic 
droplet manipulation involves the actuation of magnetic particles by a moving external 
magnetic field generated by a permanent magnet or an electromagnet. As the magnetic 
particle is transported, it may either carry the entire volume of the droplet along with 
itself or become dissociated with the droplet, based on the relative magnitude of force 
exerted by magnetic particles to drag and capillary forces [27, 30]. Modification of these 
forces using topographical barriers [31, 32] and hydrophilic patterns [33, 34] has been 
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utilized in order to enable robust sequential processing of bioanalytes in aqueous 
reagents. Automation of magnetic particle actuation has been explored using mechanical 
actuators such as linear [35, 36] and rotary [37, 38, 41][37,38,41] stages, and also using 
electromagnetic actuators such as a planar coil array [39, 40, 48]. One significant utility 
of droplet platforms utilizing magnetic particles stems from their scalability to any 
biochemical assays utilizing solid phase capture of analytes. Commercial efforts to 
develop integrated nucleic acid testing platforms utilizing magnetic particle-based 
bioassays have already been demonstrated by Hologic’s Tigris DTS system [24] and BD 
ViperXTR system [49]. Integration of sample preparation and enzymatic amplification 
chemistries such as PCR has been demonstrated by a number of magnetofluidic droplet 
platforms [31-34, 40], suggesting that droplet platforms may present a possible future 
direction toward further miniaturization. In addition to the two main actuation 
mechanisms, several other modes have been explored for droplet and particle 
manipulation and are relevant for discussion. Of particular note is surface acoustic waves, 
which are mechanical waves propagated along the surface of elastic substrate. When a 
viscous object such as a liquid droplet is placed on the substrate as shown in Fig. 3, 
surface acoustic waves are strongly absorbed by the liquid and induce an internal 
streaming inside the droplet. This phenomenon can be utilized at low-wave amplitudes 
for droplet agitation, while larger amplitudes can deform the droplet to varying extent and 
facilitate droplet transport and fission as demonstrated by Yeo et al. [43]. Other novel 
approaches include optical and pneumatic droplet actuation. Park et al. utilized optical 
tweezers to generate dielectrophoresis-induced droplet transport for cell transport [46]. 
Meanwhile, Huang et al. recently demonstrated a superhydrophobic 
polydimethylsiloxane membrane that was pneumatically actuated to facilitate efficient 
droplet agitation and transport [47].  
2.2.3 Static droplet arrays  
Many of the aforementioned droplet-based devices – particularly microfluidic droplets 
–are limited in their ability to manipulate and monitor droplets after formation. 
Measuring reaction kinetics within individual microemulsion droplets is difficult because 
droplets are continuously transported throughout the device: real-time measurements 
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would require sophisticated tracking techniques for millions of individual droplets. 
Surface-droplet platforms to some extent overcome these challenges, but their throughput 
is limited. To overcome these difficulties, miniaturized droplets can also be indexed into 
static arrays (Fig. 2). Spatial indexing is convenient when large numbers of discrete 
reactions must be executed and monitored. Such array-based technologies have wide-
ranging applications in diagnostics, drug discovery and cell biology. Arrayed reactors 
allow for parallel processing and real-time monitoring of biological assays. Several 
techniques have been developed to enable facile generation of static droplet arrays. The 
ability to create high-density arrays of small volume chambers in microfluidic devices 
provides a useful platform for digital analysis of biomarkers. Emulsion-based methods 
can achieve high numbers of reactions, but many have complicated workflows and often 
require offline incubation. In contrast, array-based devices offer advantages of simplified 
workflow and analysis speed. Fluidigm has commercialized a number of valve-based 
digital PCR devices with single nucleotide resolution. In addition, Life Technologies has 
developed platforms for digital PCR after acquiring collaborator BioTrove. In addition, 
there have been a number of technologies developed in academic settings. Recently, Men 
et al. demonstrated digital PCR in an array of femtoliter chambers allowing for a reaction 
density of 20000 mm
2
 [50]. Heyries et al. developed a valvefree microfluidic digital PCR 
device that performs a million single-molecule PCRs in uniform arrays of picoliter-
volume chambers with densities up to 440,000 reactions cm-2 [51]. The different 
platforms for microfluidic arrays and their applications will be reviewed in more detail in 
the following sections.  
 
2.3 Applications of droplet platforms  
2.3.1 Traditional technologies for digital analysis  
In 1992, Sykes et al. introduced digital PCR as a method to quantify initial template 
numbers from unknown samples [52]. An additional benefit of this technique was the 
ability to detect rare targets in a milieu of competing sequences. In 1999, Vogelstein and 
Kinzler invented the term ‘digital PCR’ [53]. This work paved the way toward digital 
analysis of nucleic acids as well as single cells. An excellent review on digital PCR 
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strategies and their role in personalized medicine was recently published [54]. To make 
dPCR feasible as a clinical tool required miniaturization. True digital PCR requires 
performing hundreds of thousands of reactions per sample. Liquid handling robotic 
systems have reached their limits as the smallest reaction volumes now approach 
approximately 1 ml. As a step toward realizing dPCR as a clinical tool, Vogelstein and 
Kinzler developed a technology called Beads, Emulsion, Amplification, Magnetics 
(BEAMing) [55, 56]. Beaming refers to the process of emulsification in bulk. In one 
study, circulating mutant cDNA was quantified using BEAMing, representing a 
personalized approach for assessing disease in subjects with cancer [57]. However, bulk-
created emulsions are limited due to the lack of control over droplet sizes. The size 
polydispersity in BEAMing limits the reliability of encapsulating a single DNA molecule 
per droplet and the ability to perform quantitative measurements. In contrast, generating 
droplets in microfluidic systems has the advantage of creating monodisperse sample 
volumes that improves reaction conditions (Fig. 1). Commercially available platforms for 
emulsion digital PCR are marketed by Bio-Rad Laboratories and RainDance 
Technologies. Monodisperse droplets are generated and then collected in an Eppendorf 
tube to order to perform PCR thermocycling step off-chip. Detection of the PCR products 
requires reinjection of droplets into a microfluidic channel to analyze the fluorescent 
signal. Commercial emulsion-based PCR systems are becoming more prevalent in the 
research community for digital analysis of biomarkers, and microfluidic droplet 
technology is expected to play a pivotal role as an enabling technology.  
 
2.4 Microfluidic droplet platforms applications  
2.4.1 Integrated platforms for genetic mutation detection  
Droplet microfluidics affords the opportunity to perform sensitive and quantitative 
methods for detecting genetic markers. RainDance technologies has developed a droplet-
based method, based on digital PCR, which allows the highly sensitive and quantitative 
detection of mutations within a large excess of wild-type sequences [58]. In a recent 
study, single-target DNA molecules were encapsulated in microdroplets with fluorogenic 
TaqMan probes specific for mutated and wild-type KRAS. After droplet generation, 
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droplets were collected in an Eppendorf tube and incubated. Then the fluorescence of 
each individual droplet was measured. Because amplified mutant DNA and wild-type 
DNA gave fluorescent signals in different channels, the ratio of wild-type to mutant DNA 
was able to be calculated. This strategy enabled the precise determination of mutant 
allelic specific imbalance in several cancer cell lines and the precise quantification of a 
single mutated KRAS gene in a background of 200,000 unmutated KRAS genes. 
Furthermore, a 6-plex assay for six common mutations in KRAS codon 12 was 
demonstrated with just two fluorophores in a single experiment. This multiplexing was 
achieved by varying the concentration of the different fluorogenic probes, leading to an 
identification of the targeted gene alteration on the basis of fluorescent color and intensity 
[59]. This platform was recently used to perform multiplex emulsion-based PCR applied 
to detecting mutations in circulating DNA (ctDNA) prepared from clinical plasma 
samples [60]. In conventional techniques, the moderate sensitivity of mutation detection 
has limited the detection of ctDNA. In contrast, with this droplet-based platform, the 
sensitivity was high enough to detect mutations in ctDNA obtained by noninvasive blood 
collection. Another recent study demonstrated high-throughput droplet digital PCR for 
absolute quantification of DNA copy number [61]. This high-throughput system enabled 
processing of 20,000 PCR reactions per sample using conventional TaqMan assays with a 
96-well plate workflow. Massive partitioning by the droplet digital PCR system resulted 
in higher precision and sensitivity than conventional real-time PCR. Accurate 
measurement of germline copy number variation was demonstrated. In addition, for rare 
alleles, sensitive detection of mutant DNA in a 100,000-fold excess of wild-type 
background was demonstrated. Finally, absolute quantitation of circulating fetal and 
maternal DNA from cell-free plasma was performed. The analysis was performed by 
endpoint fluorescence analysis of the content of the droplets. This platform is now being 
commercialized by Bio-Rad and has been demonstrated in other studies [61]. Both of 
these platforms have demonstrated the capability of high-resolution detection of 
biological molecules. However, they are limited to the analysis of a homogeneous sample 
and are incapable of high-throughput analysis of multiple samples against a large library 
of probes. Examples of applications that require high degrees of multiplexing include 
single-nucleotide polymorphism analysis and genotyping required for identification of 
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genes associated with common diseases. To address this need, we recently developed a 
droplet platform (Fig. 4) capable of on-demand generation of microfluidic droplets of 
combinatorial mixtures of samples and reagents [62]. This platform employs a linear 
array of sample plugs as an input to the device. A preformed linear array of sample plugs 
separated by a carrier fluid is injected from the cartridge into the microfluidic device, 
where each plug is chopped by a pneumatic valve into daughter droplets. The daughter 
droplets are then directly injected with reagents. The microfluidic design features a robust 
fusion module, which exploits local channel geometry, for synchronization-free injection 
of reagents into each sample daughter droplet. After reagent injection into a sample 
droplet, our microfluidic device introduces additional carrier fluid containing surfactant 
to the channel containing the sample-reagent hybrid droplet array to prevent unwanted 
merging of these droplets on the device. We believe this approach has the potential to 
broaden the applications of microfluidic droplets by allowing the generation of 
combinatorial mixtures of droplets, which many screening reactions require.  
2.4.2 Integrated platforms for targeted enrichment for sequence-based studies  
Attempts have been made to expand the capacity of droplet platforms for multiplexed 
analysis. One well-known platform has been developed by RainDance Technologies for 
massively parallel PCR enrichment for DNA sequencing. Microdropletbased PCR 
enrichment for large-scale targeted sequencing is valuable in enabling sequencing-based 
studies of genetic variation in large populations. Recently, this enrichment approach 
based on microdroplet PCR, which enables 1.5 million amplifications in parallel, was 
described [63]. This platform involves generation of a large library of PCR reagent 
droplets by a microchip. These droplets are then collected off-chip and merged with 
sample droplets generated from a DNA sample on a second droplet generation device. 
These sample–reagent hybrid droplets are then collected in standard PCR tubes for 
thermocycling, followed by fluorescence detection and sequencing. Fig. 5 shows a 
schematic of this microdroplet PCR workflow. Since then, this same method has been 
used for detecting somatic tumor mutations in heterogeneous samples [64]. More 
recently, this PCR enrichment method in microdroplets was used to identify 43 forms of 
monogenic diabetes or obesity [65]. Although promising, this platform cannot be used for 
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applications that require real-time detection. Namely, in this scheme the content of each 
individual droplet is unknown and is decoded offline by nucleic acid sequencing. One 
solution to this problem is to associate an optical code (based on fluorescence intensity) 
with each reagent prior to mixing with the sample. This approach is limited to a small 
number of codes due to the small allowable number of fluorophores without spectral 
crosstalk and the dynamic range of the optical detection setup being used. One way to 
circumvent the need for barcoding would be to perform spatial indexing of droplets [62].  
2.4.3 Integrated platforms for targeted enrichment for single-cell studies  
Droplets can be used for confinement and manipulation of single cells into 
microfluidic droplets, making them ideal for conducting high-throughput single-cell 
studies. The potential of droplet microfluidics to be a powerful tool for single-cell studies 
has been shown with demonstrations of single-cell screening assays. Because of the small 
operating volumes of droplets (picoliter-to-nanoliter range), concentrations of cellular 
genetic or proteomic materials are higher and can increase measurement sensitivity. 
Huebner et al. described the preparation of droplets containing individual cells and 
subsequent detection of fluorescent proteins in the cells with simultaneous measurement 
of droplet size, fluorescence and cell occupancy [66]. Joensson et al. demonstrated 
detection of the cell-surface biomarkers CCR5 and CD19 on single human monocytic 
cells using enzymatic amplification in droplets [67]. Boedicker et al. demonstrated the 
rapid detection and drug susceptibility of single bacterial cells in droplets using a 
fluorescent cell viability indicator assay [68]. Brouzes et al. performed high-throughput 
screening of a drug library for its cytotoxic effect against human monocytic U937 cells 
[69]. However, this method required an optical barcoding scheme that limits the 
applications of this method – only eight library members (different concentrations of the 
drug) were screened. Zeng et al. demonstrated the detection of pathogenic Escherichia 
coli cells in a background of normal E. coli K12 cells using a microfluidic droplet 
generator array [70]. However, this platform requires PCR reactions to be performed off-
chip. Rane et al. recently demonstrated amplification-free genetic detection of single 
pathogenic cells [71]. This device (Fig. 6) offers a simple and fully integrated approach to 
include all assay steps, including cell isolation, lysis, probe-target binding and 
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fluorescence detection. Each of these steps is performed within microfluidic droplets. 
Single-cell sensitivity was achieved through the platform by a two-pronged approach. 
Stochastic confinement of single cells within picoliter droplets was used to maintain a 
low-abundance intracellular target of interest from single cells at high concentrations. In 
addition, the microfluidic platform was coupled with highly sensitive confocal 
fluorescence spectroscopy for sensitive detection of target biomolecules from individual 
droplets. The capability of the device to perform ‘sample to answer’ pathogen detection 
of single cells was demonstrated using E. coli as a model pathogen. This indicated the 
promise in utilization of the platform with clinical samples with appropriate testing and 
optimization of assay conditions. Although the functioning of the device was 
demonstrated for pathogen detection, the platform is versatile enough to be applied 
toward other single-cell studies.  
 
2.5 Surface droplet platform applications  
Testing of nucleic acid biomarkers is another major arena where microfluidic droplet 
technology is being studied. While immunoassays may be useful in assessing the 
presence of abundant macromolecular targets, the high level of sensitivity and specificity 
provided by enzymatic amplification of nucleic acid targets provides a strong motivation 
for developing these technologies. The wide range of fluidic operations enabled by open-
surface droplet platforms, together with their capacity for miniaturization, places these 
technologies in a unique vantage point in delivering enzymatic nucleic acid amplification 
tests in point-of-care settings. A ubiquitous feature of droplet-based nucleic acid 
platforms is surface-modified magnetic particles, which are essential for extraction and 
retention of nucleic acids through various washing and incubation steps. Initially 
demonstrated by Vogenstein and Gilliespie [72] using glass beads, solid-phase extraction 
involving the adsorption of duplex DNA to silica is a convenient technique for purifying 
DNA from biological samples and transporting them through various reagents. In this 
section, examples of surface droplet platforms that explore the various aspects of nucleic 
acid testing, including sample preparation and enzymatic amplification, will be discussed. 
To date, various droplet platforms have made significant progress in combining sample 




2.5.1 Integrated platforms for pathogen detection  
Nucleic acid detection via amplification is an effective technique in identifying 
pathogens and provides some key advantages over culture-based techniques including 
shorter turnaround time, assay sensitivity and the ability to assess fastidious samples [73]. 
Magnetofluidic droplet platforms demonstrated by Pipper et al. [34] and Zhang et al. [31] 
combined solid-phase DNA extraction and PCR amplification to create sample-to-answer 
analytical platforms (Fig. 7). Isolation of pathogenic nucleic acid targets and subsequent 
detection via real-time PCR demonstrates the potential of such platforms in mobile 
biosurveillance, including pathogen identification and viral load quantification. In 
addition, these platforms could be extended to perform multiplexed reactions in a single 
mixture with molecular beacon probes in order to detect a panel of pathogens 
simultaneously [74]. An alternative method of detecting multiple gene targets is by 
performing amplification reactions from the same DNA isolate in separate reaction wells. 
To this end, Zhang and Wang developed a SET-based integrated platform capable of 
extracting and aliquoting genomic DNA before performing multiple PCR reactions 
simultaneously using unique primer sets [41]. Integrated platforms for genetic mutation 
detection Alongside pathogen identification, genetic mutation detection is also an 
important aspect of genetic diagnostics. Droplet based platforms designed to retrieve 
sequence-specific information have been proposed in several instances. Miniaturized 
pyrosequencing platforms have been pioneered on EWOD devices by Boles et al. [26], 
suggesting a potential direction for a small-scale DNA sequencer if sample preparation 
could be integrated. While sequencing techniques provide the most comprehensive 
information regarding an unknown nucleic acid target, the high level of fidelity and time 
required to process sequencing samples preclude their use in point-of-care settings. A 
recent work by Huang et al. [47] utilized gold nanoparticles functionalized with 
oligonucleotide probes on a pneumatically actuated droplet device, inducing visible color 
changes based on hybridization mismatches. While the simplicity of readout and the 
ability to detect sequence mismatches is encouraging, this approach has only been 
demonstrated for abundant copies of single-stranded synthetic targets and may be 
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difficult to apply in biological samples where amplified DNA targets are double-stranded 
and sequence variation is more often heterogeneous. In light of this, melting curve 
analysis has recently emerged as a potential alternative to sequencing in rapid diagnostic 
applications [75]. This technique monitors the dissociation of double-stranded DNA 
during heating by measuring the fluorescence emitted by DNA intercalating dyes [76]. 
By monitoring the fraction of remaining double-stranded DNA as the temperature is 
gradually increased, thermodynamic properties associated with the sequence are resolved 
as a function of temperature. Since the dissociation characteristics of a DNA strand are a 
function of base composition and length, samples containing mutations generate melting 
profiles that are different from their wildtype counterparts. Melting curve analysis is 
directly compatible with conventional real-time PCR workflow since it requires only a 
single universal primer pair for product amplification, in contrast to other PCR-based 
genotyping assays such as allele specific PCR  [77]and allele-specific oligonucleotide 
probes [78]that require additional probes for mutation identification. In a recent study, 
Shin et al. demonstrated identification of a single-nucleotide polymorphism in the KRAS 
oncogene using a melting curve-based approach [32]. In this work, open-surface 
magnetic droplet manipulation was used to combine DNA extraction and amplification 
via PCR into a single streamlined process (FIGURE 8).  
 
2.6 Static droplet array applications  
Droplets immobilized in high-density indexed arrays enable high throughput time-
lapse imaging of biological reactions. For example, in the case of PCR, arrays afford the 
ability to monitor the ‘response curve’ – or how levels of DNA change over the course of 
amplification. In turn, this capability can help eliminate false readings caused by 
nonspecific labeling of DNA sequencing [79]. In the following section, we will review 
some commercial technologies as well as technologies developed in academic research 
labs for performing array-based reactions.  




Two companies that have developed various commercialized microfluidic PCR 
platforms are Fluidigm and Life Technologies. Fluidigm has an array of digital PCR 
products, including one for real-time digital PCR, Fluidigm qdPCR 37KTM IFC. Life 
Technologies offers OpenArray, with custom formats to allow tailored analysis according 
to the level of sensitivity or precision required. Both platforms have isolated microfluidic 
reaction chambers that allow real-time monitoring of amplification. Results are generated 
by calculating the number of positive reaction chambers and equating it to the number of 
target copies present. A different approach to partitioning chambers for digital PCR is 
achieved with the ‘SlipChip’ (Fig. 9). The SlipChip is a microfluidic platform that 
manipulates liquid samples from picoliter-to-microliter scales by relative movement of 
patterned glass plates [80]. The SlipChip has been previously used for PCR [81, 82] and 
digital isothermal amplification [83]. In one recent paper, HIV and hepatitis C loads were 
detected on a platform for use in point-of-care and resource limited settings using the 
SlipChip [84]. In addition to the SlipChip, several other platforms have been proposed. 
Recently, Heyries et al. [51] developed a megapixel digital PCR device that partitions 
samples based on surface tension. High-fidelity single DNA molecule amplification was 
achieved in 1,000,000 parallel reactors. Furthermore, this device boasted a dynamic range 
of 107 and single-nucleotide-variant detection below one copy per 100,000 wildtype 
(FIGURE 9). In another recent study, an integrated on-chip valve-free and power-free 
microfluidic digital PCR device was developed by making use of a novel method for self-
priming compartmentalization and simple dehydration control for single DNA molecule 
detection [85]. The device contains 5120 independent 5 nl microchambers, allowing the 
samples to be compartmentalized completely. Using this platform, three different 
abundances of lung cancer-related genes were detected to demonstrate the ability of the 
microchip to amplify single copies of target DNA. In a different approach, a spinning 
disk platform for microfluidic digital PCR was developed [86]. This design loads the 
sample into nanoliter-sized compartments by centrifugation, eliminating the need for 
valves and pumps and reducing microfluidic loading time. The disk passively divides a 
spun sample into thousands of compartments, reducing chip disposable costs. PCR is 
performed on the rotating disk by rapid thermocycling in an air chamber, reducing 
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thermocycling time. After PCR, each compartment is interrogated for a positive/negative 
signal by fluorescence imaging. PCR was demonstrated in less than 35 min.  
2.6.2 Integrated platforms for protein detection  
 
Array-based devices have also been used for protein detection. In one recent study, a 
microfluidic protein chip was developed for an ultrasensitive and multiplexed assay of 
cancer biomarkers [87]. Aqueous-phase synthesized quantum dots were employed as 
fluorescent signal amplifiers to improve the detection sensitivity. The device possessed 
ultrahigh femtomolar sensitivity for cancer biomarkers and could be used directly in 
serum.  
 
2.7 Expert commentary & five-year view  
 
The development of miniaturized droplet-based systems for biomarker analysis is 
rapidly expanding. Several droplet-based and array technologies have been 
commercialized and served as important tools in impactful biomarker studies. Such 
highly sensitive and quantitative droplet-based platforms afford researchers the 
opportunity to explore complex landscapes of genetic interactions. In the future, disease 
associations may be discovered and elucidated as a result of these new droplet-based 
technologies. The three different branches of droplet-based analysis – microfluidic 
droplets, surface-based droplet platforms and array-based technologies – are indicated for 
use in different applications. Microfluidic droplet-based devices boast extremely high-
throughput – millions of discretized droplets originating from a single sample can be 
analyzed on a microfluidic droplet device – allowing the identification of rare alleles and 
alleviating the need to run multiple titrations for quantitation. Furthermore, by integrating 
valves, these platforms can perform true combinatorial screening that is necessary for 
many applications like genotyping. In addition, researchers have demonstrated the ability 
to characterize single cells. In contrast to microemulsions, surface-based droplet 
platforms generally deal with larger volumes and provide an opportunity to develop 
highly automated, miniaturized diagnostic systems. These platforms may function as 
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portable bench-top environments that dramatically shorten the transition of a bench-top 
assay into a point-of-care format. Finally, array-based devices afford relatively high-
throughput but the number of reactions is limited by the number of compartments on a 
single device. One distinct advantage is that array-based devices allow real-time 
monitoring of biological reactions. In the future, droplet-based devices may become 








Figure 2.1. Schematic of digital PCR.  
Conventional bulk analysis (left panel): if a rare target is present among an excess of competing ‘normal’ targets, an 
averaged signal will be acquired. In contrast, droplet-based PCR (right panel) is more quantitative and allows 
encapsulation of targets and reagents into droplets. The number of target DNA molecules can be calculated using 








Figure 2.2. A conceptual diagram of droplet microfluidics, surface droplet platforms and static droplet arrays.  
Droplet microfluidics: emulsions of water-in-oil droplets are formed. Droplets can be generated by shearing water-in-
oil to form droplets in a method called flow focusing (A). Surface droplet platforms: in this approach, aqueous 
reservoirs in the nanoliter-to-microliter range are manipulated individually on an open planar substrate rather than 
inside the microchannels (B). Static droplet arrays: droplets may also be spatially indexed in 2D arrays (C). These 
highly miniaturized, parallel reactors can be monitored in real time. Reproduced by permission from [51] Macmillan 








Figure 2.3. Schematics illustrating various modes of droplet actuation on surface.  
(A) Electrowetting-on-dielectric in a two-layer configuration, with a reference electrode on top and an array of control 
electrodes on the bottom. (B) Magnetofluidic actuation performed using a permanent magnet, which exerts force on 
magnetic particles contained inside a droplet and induces droplet transport or particle extraction. (C) Surface acoustic 
wave actuation (SAW) utilizes interdigital transducer patterned on a piezoelectric substrate, which generates acoustic 
waves along the substrate surface. When a droplet is placed on the surface, energy transported through SAW is 










Figure 2.4. Droplet platform for on-demand generation of combinatorial mixtures of samples and reagents.  
In this platform, the use of valves to create droplets facilitates control over the precise composition of the droplet. 
Using this technique, the ability to generate highly combinatorial mixtures was demonstrated. Step 1: a capillary 
attached to the microfluidic device injects sample plugs separated by immiscible carrier fluid. Step 2: a pneumatic 
valve chops these plugs (~200 nl) into smaller daughter droplets (~20 nl). Step 3: daughter droplets are stretched in the 
fusion zone and reagents are injected directly into the droplets. Step 4: the hybrid sample–reagent droplets are 
stabilized with carrier fluid containing surfactant. Step 5: sample–reagent droplets travel through a transition in cross 
section. Step 6: finally, sample–reagent droplets are incubated in the incubations zone. Reproduced with permission 








Figure 2.5. Microdroplet PCR workflow.  
(A) Here, a primer library is generated by emulsifying different primers and collecting them in a single tube. (B) 
Genomic DNA is processed and collected. (C) Primer droplets and DNA droplets are reinjected on to a chip for fusion. 
(A) Here, a primer library is generated by emulsifying different primers and collecting them in a single tube. (B) 
Genomic DNA is processed and collected. (C) Primer droplets and DNA droplets are reinjected on to a chip for fusion. 
Droplets are then collected into an Eppendorf tube and then incubated offline. The emulsion is then broken and 








Figure 2.6. Amplification-free genetic detection of single pathogenic cells on a droplet-based microfluidic device.  
Droplets are generated by shearing water-in-oil to form droplets in a method called flow focusing. In this example, 
pathogenic cells are encapsulated within droplets, lysed and then detected inline [71]. A peptide nucleic acid 
fluorescence resonance energy transfer probe (PNA beacon) is used to detect 16S rRNA present in pathogenic cells. 
The microfluidic platform was coupled with highly sensitive confocal fluorescence spectroscopy for sensitive detection 









Figure 2.7. Real-time PCR droplet platforms for integrated sample processing and detection.  
Zhang et al. (top panel) demonstrate amplification of the 16S ribosomal RNA gene from Escherichia coli using a 
TaqMan real-time PCR assay [31]. Chiou et al. (bottom panel) demonstrate real-time amplification of the KRAS 
oncogene target from genomic DNA that was extracted on chip directly from human whole blood [40]. Reproduced 









Figure 2.8. Melting curve analysis for genetic mutation detection using an integrated droplet platform.  
(A) Shows the principles of melting curve analysis. As the temperature is increased, duplex DNA is dissociated along 
with double-stranded DNA binding dyes, resulting in a decrease in fluorescence. (B) Shows an example of melting 
curve analysis for identification of a single-nucleotide polymorphism within a 544-bp fragment of the HTR2A gene. 
Bottom panel (C) Shows the layout of magnetically actuated droplet cartridge for performing genomic DNA isolation, 
PCR and melting curve analysis from biological sample. (D) Shows temperature profile achieved at the incubation 
chamber, including the initial PCR amplification and thermal ramp for melting curve acquisition. Adapted from [76] 
and [32]. Reproduced with permission from [76]. American Association for Clinical Chemistry (2003). Reproduced 








Figure 2.9. Megapixel digital PCR and SlipChip.  
Megapixel digital PCR (left panel). (A) Schematic of megapixel digital PCR device. This device performs digital PCR 
of a single sample in 1 million small reactors. The total number of positive counts and negative counts can be precisely 
quantified. SlipChip (right panel). Rotational multivolume SlipChip well volumes: 1, 5, 25 and 125 nL). Bottom panel: 
fluorescent photograph of a multiplexed digital RT-PCR detection panel: i) measurement of internal control of 906 nt 
RNA template in HCV sample; ii) HCV control viral RNA measurement; iii) negative control for HIV (HIV primers 
with no loaded HIV RNA template); iv) HIV viral RNA measurement; v) negative control for HCV (HCV primers with 
no loaded HCV RNA template). Inset shows an amplified area from HCV viral load test. A) Adapted from [51] and 
[84]. Reproduced with permission from [51] Macmillan Publishers Ltd (2011). B) Reproduced with permission from 
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We propose a highly versatile and programmable nanolitre droplet-based platform that 
accepts an unlimited number of sample plugs from a multi-well plate, performs 
digitization of these sample plugs into smaller daughter droplets and subsequent 
synchronization-free, robust injection of multiple reagents into the sample daughter 
droplets on-demand. This platform combines excellent control of valve-based 
microfluidics with the high-throughput capability of droplet microfluidics. We 
demonstrate the functioning of a proof-of-concept device which generates combinatorial 
mixture droplets from a linear array of sample plugs and four different reagents, using 
food dyes to mimic samples and reagents. Generation of a one dimensional array of the 
combinatorial mixture droplets on the device leads to automatic spatial indexing of these 
droplets, precluding the need to include a barcode in each droplet to identify its contents. 
We expect this platform to further expand the range of applications of droplet 
microfluidics to include applications requiring a high degree of multiplexing as well as 





 Droplet microfluidic platforms are in the early stages of revolutionizing high 
throughput and combinatorial sample screening for bioanalytical applications [88-91]. 
Droplet-based systems have many advantages over conventional microtiter techniques for 
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combinatorial screening applications. Microfluidic droplets function as miniaturized 
reaction containers consist of pico or nanolitre volumes, thereby facilitating reduced 
reagent consumption and background noise [91]. Furthermore, carrier fluid shields each 
droplet, mitigating the problems of absorption onto solid surfaces and contamination. The 
high surface area to volume ratio of droplets also facilitates shorter heat and mass transfer 
times, leading faster reaction kinetics in droplets [89, 92].  
Recent publications in the microfluidic domain boast high throughput capability of 
their respective droplet-based platforms. Compartmentalization of many small droplets 
allows isolation of interfering molecules into separate volumes, thereby facilitating 
digital analysis of biological entities. Several examples have been demonstrated 
including: droplet platforms for high throughput single copy DNA amplification [93-95], 
droplet platforms for high throughput single cell screening [66, 96, 97] as well as droplet 
platforms for single organism screening [98, 99]. These droplet platforms are capable of 
high resolution screening of the biological contents at the level of the fundamental unit. 
However, they are limited to the analysis of a single sample under a homogeneous 
reagent condition. 
The aforementioned droplet platforms are incapable of addressing the needs of 
numerous applications which require high degrees of multiplexing as well as high-
throughput analysis of multiple samples. Some examples include genetic fingerprinting 
for forensics [100], single nucleotide polymorphism (SNP) analysis for crop 
improvement and domestication [101], genotyping required for identification of genes 
associated with common diseases [102] and generation of a blood donor genotype 
database for better matching between recipient and donor to prevent adverse transfusion 
reactions [103]. All these applications require multiplexed screening of a single sample 
with a panel of reagents (or markers) and rapid screening of a large number of samples to 
generate the required databases. 
In recent years, there have been attempts to expand the capacity of droplet platforms 
for the analysis of a biological or chemical sample with multiple reagents. One of the 
well-tested platforms has been the droplet platform developed by RainDance 
Technologies, for massively parallel PCR enrichment for DNA sequencing [63]. This 
platform involves a multistep approach with generation of a large library of PCR reagent 
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droplets by a microchip, followed by merging of these reagent droplets with sample 
droplets generated from a DNA sample on a second device. These sample-reagent hybrid 
droplets are then collected in standard PCR tubes for thermocycling, followed by 
fluorescence detection and sequencing. In this platform, the content of each individual 
droplet is unknown and is decoded only by offline nucleic acid sequencing. Therefore, it 
cannot be applied to other applications that require real-time detection [91]. A solution to 
this problem is to associate a unique optical-code with each reagent prior to mixing with 
the sample. However, an optical-coding scheme based on fluorescence intensity is 
practically limited to a small number of ‘codes’ due to the small allowable number of 
fluorophores without spectral crosstalk and the limited dynamic range of the optical 
detection setup being used [91]. Furthermore, the electrocoalescence technique used in 
such platforms for droplet merging is susceptible to errors of no fusion caused by an 
excess of droplets of a reagent or unintended fusion of more than two droplets due to 
highly stringent synchronization requirements [104]. A recent article demonstrated a 
picoinjector which can overcome this problem and be used to add controlled volumes of 
multiple reagents to sample droplets using electromicrofluidics [105]. However, similar 
to droplet platforms discussed earlier, the content of each individual droplet is unknown 
unless a barcode is included in each individual droplet.  
Alternatively, a series of articles adopted a cartridge technique for increasing the 
throughput of the droplet platform [106]. This technique involves generation of an array 
of reagent plugs in a capillary (cartridge), which are sequentially introduced to a simple 
microfluidic device for merging with a single substrate. The reagent plugs can be further 
digitized into smaller droplets prior to merging with the sample. As the length of the 
capillary can be very long, the number of reagents to screen against the sample is 
virtually limitless. This technique has been applied to many applications including 
protein crystallization  and study of bacterial susceptibility to antibiotics [107]. Although 
the aforementioned droplet and cartridge platforms are capable of high throughput and 
multiplexed analysis, they are still limited to screening of a single sample at a time. 
Recently, a microfluidic platform was proposed for combinatorial chemical synthesis in 
picolitre droplets, where droplets of one library of reagents were fused at random with 
droplets containing a different set of reagents [104]. This platform has the potential of 
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generating a large set of possible combinations of different reagents. However, as afore-
discussed, the unknown identity of the compounds within individual droplets precludes 
its use for many screening applications that require real-time detection.  
Here we present a droplet platform capable of on-demand generation of nanolitre 
droplets of combinational mixtures of samples and reagents, needed for biochemical 
screening applications that require multiplexing and high-throughput capability. On-
demand droplet generation and manipulation using pneumatic valves has been 
demonstrated by other groups in the past [108-110]. However, these platforms have 
focused on generating multiple reagent combinations using fixed number of inputs to the 
device, severely limiting the number of possible sample-reagent combinations being 
generated on the device. The droplet platform reported in this article uses a linear array of 
sample plugs as an input to the device, removing the limitation imposed by the number of 
inputs to the device. Initially, a preformed linear array of sample plugs separated by a 
carrier fluid is flowed from the cartridge into the microfluidic device, wherein each plug 
is digitized by a pneumatic valve into smaller sample daughter droplets. The volume of 
the resulting daughter droplet can be precisely controlled by varying the valve opening 
time and the back pressure on the cartridge containing sample plugs. The daughter 
droplets are then directly injected with reagents in a synchronization-free manner. The 
microfluidic design features a robust fusion module which exploits local channel 
geometry for synchronization-free injection of reagents into each sample daughter 
droplet. After reagent injection into a sample droplet, our microfluidic device introduces 
additional carrier fluid containing surfactant to the channel containing the sample-reagent 
hybrid droplet array to prevent unwanted merging of these droplets on the device. In the 
proposed microfluidic device, droplets are indexed by their layout in a 1D array, enabling 
the identification of the contents of each droplet by spatial indexing. Spatial indexing as a 
means for identification of droplet content obviates the need for a limiting optical 
barcoding scheme. 
 
3.2 Materials and Methods 
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3.2.1 Serial Sampling Loading System 
 The sample library was generated using a custom-designed Serial Sample 
Loading System (SSL). Fig 6.2 is a schematic illustrating the functioning of the SSL 
system. Briefly, the SSL system was designed to be compatible with Costar 96-well 
plates (Corning). Initially the wells on a Costar 96-well plate are filled with the samples 
and the carrier fluid to be used for generating the sample plug array. An Aquapel (PPG 
Industries) treated silica capillary is then attached to a capillary adapter on the SSL 
system, which is also connected to a positive pressure input. A sample well is then 
interfaced with the capillary through the capillary adapter. Application of positive 
pressure to the sealed sample well for a controlled amount of time is then used to drive a 
sample plug from the well into the capillary. This sequence of steps is then repeated to 
load alternating sample and carrier fluid plugs into the capillary (Fig. 6.2b). More 
detailed information on the structure and operation of different components of the SSL 
system can be found in the section 6.5.4.  
3.2.2 Fabrication of the Master Molds for the Microfluidic Device 
The fluidic layer on the microfluidic device features five different heights of 
microfluidic channels (Fig. 6.3b and c). As a result, the fluidic mold consists of five 
different layers of photoresist. The fluidic channel heights in these five different 
photoresist layers were expected to be 25 μm, 50 μm, 100 μm, 200 μm and 360 μm. The 
photoresist used for the 25 um layer was SPR 220-7.0 (Rohm & Haas), while the rest of 
the layers were fabricated using SU-8 3050 (MicroChem). Fabrication was performed 
using standard photolithography techniques. Briefly, a SPR 220-7.0 layer was spin coated 
on a 4 inch silicon wafer. This layer was patterned using photolithography and hard 
baked to generate a rounded channel cross section, required for effective valve closure, as 
has been described earlier [111]. For all other layers, SU-8 3050 was spin-coated on the 
wafer and patterned using standard photolithography, excluding the developing step. This 
technique was found to be very effective in preventing generation of bubbles and non-
uniform coating of photoresist on the wafer due to the presence of features from earlier 
layers on the wafer. A single developing step for all four SU-8 3050 layers was used to 
remove excess photoresist on the wafer (Fig 6.7). The control layer for the microfluidic 
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device on the other hand consisted of microfluidic channels of a single height. As a 
result, the mold fabrication for the control layer was relatively simpler, with a single layer 
of SU-8 3050 photoresist, 50 μm in height. 
 
3.2.3 Microfluidic Device Fabrication 
The microfluidic devices were fabricated using multilayer soft lithography techniques 
[111]. The protocol differed slightly from our standard protocol [112-114] due to the 
need for proper functioning of push-down valves(103) while accommodating tall features 
(up to 360 μm) on the fluidic layer. The thickness of the polydimethylsiloxane (PDMS) 
membrane separating the control layer and the fluidic layer in a microfluidic device needs 
to be less than ~50 μm, for complete valve closure at reasonable pressure (~30 PSI). 
However, the presence of fluidic regions as tall as 360 μm on the fluidic layer mold 
precluded the possibility of covering the entire fluidic layer mold with PDMS, while 
maintaining the thickness of the PDMS layer to a value less than 50 μm in the regions of 
the device containing valves. To overcome this problem, a modified three-layer 
fabrication process was developed. Detailed description of the fabrication process is 
included in section 6.5.2. 
3.2.4 Capillary–to–Chip Interface  
Following the microfluidic device fabrication, a silica capillary was attached to the 
‘capillary inlet’ on the microfluidic device (Fig. 6.3b). The 360 μm tall channel region at 
the capillary inlet accommodates a silica capillary with an OD of 360μm. A 10 mm 
section of silica capillary is inserted horizontally into this tall channel on the device until 
it is flush with the 200 μm tall fluidic channel on the device. To seal the capillary to the 
chip and prevent leakage, PDMS was dispensed around the capillary at the interface 
between the capillary and the device. The PDMS tended to crawl into the 360 μm channel 
and surround the capillary, effectively sealing the capillary-to-chip connection. The final 
assembly was baked for at least 2 hours at 80ºC before usage. 
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3.2.5 Device control  
All the inputs on the device were kept under constant pressure, with independent input 
pressure for 1) carrier fluid input, 2) all four reagent inputs and 3) carrier fluid with 
surfactant input. The pressure applied to the capillary input was controlled directly by the 
pressure controller used for the SSL system. All the valves on the device were controlled 
by an array of off-chip solenoid valves, as has been demonstrated earlier(34). We 
developed Matlab (Mathworks, Natick MA) software for computer control of the valve 
array. This software allowed us to execute a predetermined sequence of valve actuation 
with independent time control for each actuation. The opening of a valve corresponding 
to an input on the device led to the release of a droplet of fluid from that inlet into a 
central channel on the device. The volume of this droplet could be controlled through 
variation of the opening time of the valve. 
 
3.2.6 Reagents 
All the devices and capillaries were treated with Aquapel to render their surface 
hydrophobic. The testing of our platform was performed using food dyes (Ateco, Glen 
Cove, NY) to mimic different samples and reagents for easy visualization. The carrier 
fluid used to maintain the separation between sample plugs consisted of a 
perfluorocarbon (FC-3283) and a non-ionic fluorous-soluble surfactant (1H,1H,2H,2H-
Perfluoro-1-octanol) mixed in a ratio of 8:1 by volume. The carrier fluid with surfactant 
consisted of FC-40 (3M) and 2% ‘EA’ surfactant (Raindance Technologies) by weight. 
 
3.2.7 Sample plug and droplet volume estimation 
We estimated the volume of sample plugs and sample droplets generated using the 
SSL system and the microfluidic device respectively. This volume estimation was 
performed by processing the images of these sample plugs or droplets using the software 
ImageJ(104). Specifically, for sample plug volume estimation, a series of sample (blue 
food dye) plugs were generated in a silica capillary using the SSL system. A colour 
image of these plugs was taken against the while background of a ‘letter’ sized sheet of 
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paper using a standard Digital Single-Lens Reflex (DSLR) camera. This image was 
imported in ImageJ and the length scale was set to true length using the known length of 
the letter sized paper in the image. The lengths of the sample plugs were then manually 
measured for each plug using the ‘Measure’ function in ImageJ. The plug lengths could 
be converted to plug volumes with the known cross sectional area of the capillary. For 
sample droplet volume estimation, we generated droplets made of blue food dye using 
one of the four reagent inlets on the mi whole device was then imaged using a DSLR 
camera. The image was imported in ImageJ and cropped to obtain an image of the 
incubation region on the device. This image was then converted to a binary image using 
colour thresholding to identify droplets over the background image. An estimate of the 
droplet area for each droplet in the image was then obtained using the ‘Analyze Particles’ 
function. This analysis was limited to particle areas larger than a lower threshold to 
exclude any particles and occasional satellite droplets from the analysis. The droplet 
areas thus estimated were then converted to droplet volume using the known depth of the 
incubation channel region (200 μm).  
 
3.3 Results and Discussion 
3.3.1 Overall Work Flow 
Fig 6.1 is a schematic illustrating the functioning of the platform. Initially a cartridge 
(capillary) is loaded with a library of sample plugs forming a serial sample plug array: 
plugs are separated from each other by an immiscible carrier fluid. This cartridge is 
interfaced with a microfluidic device featuring multichannel architecture and pneumatic 
microvalves. The microfluidic device digitizes sample plugs into smaller daughter 
droplets on. Each sample daughter droplet then moves to the downstream fusion region 
where a specific reagent is injected into the sample daughter droplet. The reagent droplets 
are injected into the sample daughter droplet through controlled actuation of valves 
corresponding to the reagent inlets. Supp. Video 6 shows this sequence of events. No 
strict synchronization or droplet detection module is necessary for fusion of sample and 
reagent to occur as the sample droplet is elongated in the fusion area (Supp. Video 7), 
exploiting the local channel geometry. The resulting sample-reagent droplet undergoes 
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mixing and travels downstream to the incubation region on the device. After reagent 
injection, additional carrier fluid containing surfactant is released into the central channel 
on the device to stabilize sample-reagent hybrid droplets. The sequence of droplets is 
maintained throughout the device, precluding the need for a complicated barcoding 
scheme to identify the contents of each individual droplet. 
3.3.2 Capillary-to-Chip Interface 
Our prototype platform necessitated the capillary-to-chip interface design to allow for 
sample plug introduction on chip. This objective presented a unique challenge, since 
proper functioning of the platform requires smooth transition of sample plugs from the 
large ID of the capillary to shallow channels on the device in the valve regions. There 
have been demonstrations of capillary-to-chip interfaces in the past for introducing 
sample plugs from a capillary to a microfluidic device. However, the devices used don’t 
face this problem as they typically feature large channels with a valve-less design(25, 
99). The capillary interface we designed (Fig. 6.3b and c) between the capillary and 
microfluidic chip was found to be effective in minimizing plug break up as plugs moved 
from the high ID (200 μm) of the capillary to the shallow channels on chip (25 μm). This 
transition consisted of 5 different channel sections with gradually reducing channel 
heights of 360 μm, 200 μm, 100 μm, 50 μm and 25 μm. This gradual transition minimizes 
the shear stress on the sample plug as it traverses from a capillary to the shallow channels 
on the chip, preventing its breakup in transit. 
3.3.3 Droplet uniformity using mechanical valve based droplet generation 
We examined the performance of the mechanical valves on our microfluidic device for 
their capability to control the droplet size generated. To conduct this experiment, we 
primed the incubation channel on the device with the carrier fluid. We then used one of 
the reagent inlets on the device for generating droplets made of blue-colored food dye 
into the incubation channel region. The two parameters which could be used to control 
the droplet size generated from a reagent inlet are 1) Input pressure to the reagent inlet 
(Preagent) and 2) The opening time of the valve corresponding to the reagent inlet 
(Topen). Initially, we fixed the value of Preagent and generated droplets on the device for 
different values of Topen. Droplet generation was continued for each condition tested, 
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until the incubation region on the device was completely full of droplets. We then 
estimated the volume for all these droplets using the image processing technique 
discussed in the ‘Materials and Methods’ section. The mean and standard deviation of 
fifty droplets generated for each condition was plotted against Topen in Fig. 6.4b. This 
experiment was repeated for three different fixed values of Preagent. As expected, the 
linear relationship between droplet volume and Topen indicates excellent and predictable 
control of the device over droplet volume. Small standard deviation observed on the 
droplet volume also indicates excellent droplet uniformity for identical droplet generation 
conditions. This result is very important to ensure the capability of the device to generate 
droplets of various compositions on-demand. 
 
3.3.4 Sample Digitization 
 
We examined the capability of our device to digitize a set of sample plugs being 
supplied to the device into smaller sample daughter droplets. To conduct this experiment, 
we generated a set of sample plugs into a silica capillary using the SSL system. These 
sample plugs were delivered to the microfluidic device through the capillary inlet, under 
pressure provided by the pressure controller on the SSL system. For this experiment, the 
repeating sequence of steps executed on the device was as following: 1) Generate small 
droplet from a sample plug in the central channel, 2) Move the droplet towards 
incubation region with carrier fluid 3) Release small amount of carrier fluid with 
surfactant in the central channel. Repeating this set of steps led to generation of an array 
of sample droplets generated through digitization of sample plugs on the device. 
Examples of unmerged sample daughter droplets are shown in Fig. 6.6a (Sample droplets 
A, B, C and D). The order of the sample plugs in the capillary is consistently maintained 
on the device, even after the digitization operation. One shortcoming of this operation is 
the generation of non-uniform droplets towards the beginning and the end of the sample 
plugs. This is because the valve actuation sequence is continuously executed without any 
sensing of sample plug arrival on the device. However, the sample droplet uniformity is 
maintained throughout the rest of the sample plug. As the droplets generated on the 
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device are stabilized with surfactant, undesirable merging of non-uniform droplets 
originating from the front- or back-end of plugs is avoided on the device. 
3.3.5 Generation of droplets of combinatorial mixtures 
In this section we demonstrate proof-of-concept generation of combinatorial mixtures 
from sample plugs and reagent droplets on our device. For discernibility, we chose to use 
different food dye solutions to simulate different samples and reagents. Fig. 6.5 shows 
how reagent injection operations are performed in the fusion region on our device (also 
shown in Supp. Video 6). First, a sample plug travels from the capillary on to the 
microfluidic device. This plug is then chopped into a smaller sample daughter droplet. 
This droplet is then moved to the downstream fusion zone through release of carrier fluid 
in the central channel on the device. As every single input on the device is controlled 
with an individual valve, the device functions like an assembly line with complete 
temporal and spatial control over every single operation, as against typical droplet 
generating devices where the carried fluid flow is continuous. This level of control also 
implies that the operation of the device can be paused and resumed with a completely 
new valve actuation sequence, on demand without affecting the existing droplets on the 
device. None of the droplet devices reported in literature so far has this capability to the 
best of our knowledge. A reagent droplet is then injected directly into the sample 
daughter droplet (Fig. 6.5a). The volume of reagent solution injected into the sample 
droplet can be controlled through variation of the opening time for the valve 
corresponding to the reagent inlet. Supp. Video 7 provides a close-up view to how 
reagent injection is performed. The fusion zone is designed such that the sample daughter 
droplet is sufficiently elongated within a region, which overlaps with all the injection 
ports of the interrogating reagents. This elongated droplet state removes the need for 
strict positioning accuracy requirements on the sample droplet for reliable injection of 
reagent into the sample droplet. In addition to demonstrating injection of a single reagent 
in a sample droplet, we have demonstrated injection of up to four reagents into a single 
sample droplet as shown in Fig. 6.5b. The concept of droplet elongation to aid reagent 
injection can be easily scaled to accommodate tens of reagent inlets, if desired.  
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After reagent injection, the sample-reagent droplet is driven further downstream with 
the help of carrier fluid. Following this, a small plug of carrier fluid with surfactant is 
released in the central channel for stabilizing the droplets in the incubation region. Using 
this scheme we can simultaneously take advantage of a surfactant-free zone in one area of 
the chip to promote sample-reagent merging while deliberately using surfactant in 
another area to increase droplet stability and prevent unwanted droplet merging.  
Fig. 6.6 demonstrates the reliability of the fusion mechanism on our device. Fig. 6.6a 
is a table of 16 different sample-reagent combinations generated on a single chip through 
all possible merging combinations of four different sample daughter droplets (A: blue, B: 
yellow, C: green, D: water) with four different reagents (Reagent 1: orange, Reagent 2: 
water, Reagent 3: blue, Reagent 4: yellow) with the condition of merging exactly one 
sample with one reagent.  
The micrographs in Fig. 6.6b show a repeating sequence of the sample-reagent hybrid 
droplets in the incubation region of the chip. The chip is operated such that the sample 
daughter droplets are merged with a repeating sequence of four different reagents. As a 
result a repeating sequence of four possible combinations generated through mixing a 
single sample with four different reagents can be seen in each individual micrograph. 
Once a sample plug is exhausted, the sample daughter droplets generated from the next 
incoming sample plug start merging with the same repeating sequence of reagents 
generating a repeating sequence of a new set of four different sample-reagent 
combinations in the incubation region on the chip. The droplet monodispersity as well as 
the uniform spacing between droplets is clearly visible in these micrographs. The inset in 
Fig. 6.6b displays zoomed-in view of these micrographs of the incubation region 
illustrating two repeats of each sequence in the incubation region. These images also 
demonstrate the capability of the device to maintain the order in which droplets are 
generated, throughout the incubation region on the device. We have demonstrated 16 
combinations in this instance, but by employing multiple (2, 3 or 4) reagent merging with 
sample daughter droplets, as demonstrated in Fig. 6.5b, many more combinations can be 





In summary, we have demonstrated a platform capable of preparing droplets from 
combinational mixtures of a large number of samples and reagents. This is accomplished 
by synchronization-free and detection-free fusion of sample daughter droplets and 
reagents. A key benefit of this architecture is the ability to scale this device to analyze N 
samples against M reagents (N x M) where N can range from hundreds to thousands 
without accompanying increase in device complexity. Additional reagent set multiplexing 
can be accomplished analogously by introducing linear arrays of reagent set plugs similar 
to sample introduction. Furthermore, this design allows for spatial indexing, by 
maintaining the sequence of droplets from generation throughout incubation, precluding 
the need for barcoding. 
This platform presents a novel design with several important components: a unique 
SSL system which uses pressure to inject uniform volumes of sample into a capillary 
directly from an industry standard multi-well plate. This capillary is then interfaced with 
a microfluidic device using a novel capillary-to-chip connection. The microfluidic device 
is capable of combinatorial screening operations. Robust synchronization-free reagent 
injection is performed on the device based on a design which capitalizes on droplet 
elongation in the fusion zone on the device. In our prototype design up to 4 reagent 
droplets can be fused with a single sample droplet. However, by employing the same 
concept many more reagent inlets can be introduced on chip to perform merging 
operations. In addition, we have demonstrated a technique for reagent injection in 
droplets that capitalizes on controlling droplet surface chemistry by controlling surfactant 
concentration at different regions on the chip. That is, we have demonstrated a surfactant-
free environment in the fusion zone on the device, thereby promoting reagent injection in 
sample droplets while the droplets are stabilized by surfactant in the incubation region. 
For the microfluidic chip design, several areas can be explored to further enhance the 
operation of the chip. To make the transition of sample plugs from a capillary to the 
microfluidic device more gradual a photolithography process employing a grayscale 
mask could be used. This approach can generate very gradual reduction in channel cross 
section from a large capillary to shallow microfluidic channels on the device as against 
the 5 step reduction demonstrated in the current version of the device. Furthermore, 
reagents may be loaded in cartridge format to further enhance multiplexing capabilities. 
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We expect the platform described here to be a promising candidate for combinatorial 








Figure 3.1. A schematic of the sample screening platform.  
Step 1: A cartridge is loaded with a library of sample plugs separated by an immiscible carrier fluid. This cartridge is 
interfaced with a microfluidic device. Step 2: On-demand digitization of incoming sample plugs into smaller daughter 
droplets. The volume of individual daughter droplets can be controlled by valve opening time and back pressure on the 
cartridge. Step 3: By exploiting the cross sectional area of the central channel, the sample daughter droplet is stretched 
in the “Fusion Region”. This approach allows for robust, synchronization-free injection of up to four reagents 
simultaneously directly into the daughter droplet. The volume of reagent injected is controlled through modulation of 
back pressure and valve opening time corresponding to the reagent inlet. Step 4: Once sample and reagent have been 
combined into one droplet, the droplets are stabilized with carrier fluid containing surfactant to prevent unwanted 
droplet coalescence downstream.Step 5: Sample–reagent droplets travel to an incubation channel. Step 6: The sample–
reagent droplets are incubated while maintaining their sequence in downstream incubation channels. This approach 








Figure 3.2. The Serial Sample Loading (SSL) system. 
A custom SSL system was designed which employs positive pressure to inject a sample plug into a microcapillary from 
a standard multi-well plate. A custom capillary adapter in the SSL system provides an interface between a 
microcapillary and a multi-well plate. This adapter can seal a well on the multi-well plate, thus generating a temporary 
pressure chamber inside the sample well. A pressure input on the adapter can then be used to apply controlled pressure 
to the fluid inside the sample well. This positive pressure drives a small plug of sample from the well into the 
microcapillary. Following this, the seal is broken and the multi-well plate is moved to seal another sample well with the 
capillary adapter. This sequence of steps is repeated to generate a sample library into the microcapillary. b) An image 
of afood dye sample plug array generated using the SSL system. Each sample plug is separated from each other by an 








Figure 3.3. Microfluidic Device Design. 
a) Photograph of a prototype device. The microfluidic device has a multichannel architecture: 1) The central channel 
with fusion region and incubation region (purple), 2) Capillary inlet, 3) Reagent inlets: reagent 1 (pink), reagent 2 
(orange), reagent 3 (green), reagent 4 (turquoise) and surfactant oil inlet (yellow). The valves on the device (V1–V7) 
are indicated by a turquoise dye. b) A scan of the capillary inlet region, indicating the height difference between 
different sections of the capillary inlet to facilitate smooth sample plug transition from the large ID of the capillary to 







Figure 3.4. Control of droplet volume and droplet uniformity using mechanical valve based droplet generation. 
a) Micrograph of the incubation region on the microfluidic device filled with reagent droplets generated using 
sequentially increasing valve opening times (Ton = 0.3, 0.4, 0.5, 0.6, 0.7, 0.8 s) for a fixed back pressure on the reagent 
inlet (Preagent = 5 psi). This resulted in a linear array of repeats of a sequence of six droplets, with each droplet 
increasing in volume. b) A plot of droplet volume versus the valve opening time (Topen) for a valve corresponding to a 
reagent inlet for three different values of back pressures applied to the reagent inlet (Preagent = 2.5, 5 and 7.5 psi). The 
droplet volumes plotted are an average of volumes estimated from 50 droplets for each condition. The error bars in the 









Figure 3.5. Demonstration of reagent injection in sample daughter droplets.  
a) Time series of images indicating reagent injection into sample daughter droplets at the ‘Fusion zone’ on the device. 
A sample daughter droplet (yellow) is released from the capillary inlet and is halted in the ‘Fusion zone’ by actuating a 
valve upstream which controls carrier fluid injection into the central channel on the device. A reagent (blue) is released 
and injected directly into the sample droplet. The elongated configuration of the sample daughter droplet in the ‘Fusion 
zone’ ensures robust reagent injection operation on the device without the need for precise sample droplet positioning. 










Figure 3.6. Photographs of the incubation region indicating the multiplexing capability of the device.  
a) Table with micrographs indicating combinatorial mixture droplets generated on the device using four different 
samples [Sample A (blue), Sample B (yellow), Sample C (green), Sample D (water)] and four different reagents 
[Reagent 1 (orange), Reagent 2 (water), Reagent 3 (light blue), Reagent 4 (yellow)]. Droplets 1A–4A, 1B–4B, 1C–4C, 
and 1D–4D are each generated from a combination of the sample and reagent in the corresponding column and row, 
respectively. For example, Droplet 1A is the combination of sample A with reagent 1. b) The left panel shows four 
different micrographs showing repeating sequences of sample daughter droplets generated from a single sample plug 
merged with four different reagents on a single device. The right panel shows a zoomed in version of a small section of 
the micrographs from the left panel for easy visualization of the droplet sequence. The droplet identification codes in 
this panel are the same as those used in subfigure a. Note: The sequence of droplets seems to be going in the opposite 






3.5 Supplementary section 
3.5.1 Mold Fabrication 
The work flow used for fabricating the fluidic layer mold is illustrated in Fig 6.7. The 
mold consists of five different layers of photoresist with heights of 25 μm, 50 μm, 100 
μm, 200 μm and 360 μm. The photoresist used for the 25 μm layer was SPR 220-7.0 
(Rohm & Haas), while the rest of the layers were fabricated using SU-8 3050 
(MicroChem). Initially a 25um tall SPR 220-7.0 layer was spin coated on a silicon wafer. 
This layer was patterned using photolithography and hard baked to generate a rounded 
channel cross section, required for effective valve closure. Rest of the layers were 
fabricated by stacking and patterning multiple layers of SU-8 3050 on the wafer. All the 
steps required for standard photolithography (Soft Bake, Exposure and Post Exposure 
Bake) are conducted for each layer of SU-8 3050, except the developing step. This step is 
conducted in common for all layers after the last SU-8 layer is patterned to remove 
excess unexposed photoresist from the wafer (Fig 6.7). This technique was found to be 
very effective in preventing generation of bubbles and non-uniform coating of photoresist 
on the wafer due to the presence of features from earlier layers on the wafer. 
3.5.2 Device Fabrication and Operation 
The microfluidic device for our experiments was fabricated using multilayer soft 
lithography technique. Standard dual layer microfluidic devices with push-down valves 
fabricated using polydimethylsiloxane (PDMS) require shallow fluidic channels to make 
sure the layer of PDMS between the fluidic and control layer is sufficiently thin (~50um) 
for complete closure of valves at low pressures (<30psi). The requirement of shallow 
fluidic channels is incompatible with our chip design. So we developed a modified 
fabrication process for our device. This modified soft lithography process is outlined in 
Fig 6.8. For this modified fabrication process, three different batches of PDMS were 
mixed. These varied in composition, and base to crosslinking agent ratios of 15:1, 10:1 
and 6:1 were used, respectively. These batches were thoroughly mixed and degassed 
prior to use for device fabrication. The control layer mold was spin coated with a thick 
layer (~1 mm) of 6:1 PDMS and baked at 80oC for 7 mins. A thin layer of 15:1 PDMS 
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was spin coated on the fluidic layer mold. The device was designed such that the valve 
regions on the device were placed in areas surrounded by shallow fluidic channels, 
ensuring uniform coverage of these regions with a thin layer of PDMS. The PDMS on the 
fluidic layer mold was then baked at 80oC for 6 minutes. The PDMS was removed from 
the control layer mold and the control layer was cut to the exact size of the valve regions 
on the device, while not covering any channels higher than 50 μm on the device (Fig 6.8). 
The control layer PDMS pieces were aligned with baked PDMS layer on the fluidic layer 
mold under a stereoscope. The fluidic layer mold with the aligned control layer was 
baked at 80oC for 20 mins to promote adhesion between the control layer and the fluidic 
layer. Following this, 49.5 g of 10:1 PDMS was poured on the fluidic layer mold, 
covering all features on the fluidic layer mold with a 3-4 mm thick layer of PDMS. The 
fluidic layer mold was then baked for at least 30 minutes at 80oC. Following this, the 
PDMS was removed from the fluidic layer mold and individual devices were cut. Fluidic 
access holes were then punched into the device and the device was bonded to a 
coverglass through oxygen plasma treatment. 
3.5.3 Fusion Zone design  
An important aspect of our microfluidic device is the robust synchronization-free 
fusion mechanism. This mechanism utilizes the cross-sectional area of the central channel 
on the microfluidic device for the merging operation. Fig 6.9 demonstrates the design 
criteria of the fusion region on our device. In our current design, the dimensions of the 
fusion zone (19 nL). This volume of the fusion zone corresponds to the minimum volume 
of the sample daughter droplet, such that the droplet spans the entire length of all the 
reagent injection sites on the chip. As a result, the sample daughter droplet position 
doesn’t need to be finely controlled to inject different reagents in it. If there is a need for 
smaller reaction volumes, the cross-sectional area of the central channel can be modified 
to reduce the minimum volume of the sample daughter droplet required. For instance, 
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in minimum required droplet volume from 19 nL to 3.8 nL (Fig 6.9). A similar approach 
can be used to accommodate more than four reagent inlets on the chip. 
3.5.4 Serial Sample Loading System 
3.5.4.1 Background 
High throughput sample processing is a critical requirement for a large number of 
industries. Some examples include the agricultural, pharmaceutical and biotechnological 
industries(105). As a result, there is a constant drive for innovation in sample processing 
techniques, supporting these industries. One major breakthrough in this domain has been 
the application of various robotic sample handling techniques, to improve the speed of 
sample processing as well as to reduce the volume of reagents used per reaction. 
Although the robotic systems have become incredibly fast at sample processing 
operations, they are typically limited to operating with standard multi-well (96, 384 and 
1536 well) plates. As a result, the typical sample volume consumption is on the order of 
microliters per reaction for such systems(105). Recent advances in the microfluidic 
domain show promise in overcoming this limitation of the robotic systems. Droplet-based 
microfluidic systems have been shown to be capable of performing biomolecular 
screening with sample volumes as low as picoliters(1, 5, 8, 48, 69). However, introducing 
a large number of samples on a miniature microfluidic device is difficult since it is 
impractical to have hundreds to thousands of sample inlets to a single microfluidic 
device. Furthermore, the tubing used for supplying the samples to such a microfluidic 
device would already consume orders of magnitude more sample than is required for the 
actual analysis on the microfluidic device. So, there is a need for an efficient way to 
transport a large number of samples to a microfluidic device. Ideally such a sample 
transport system would be flexible enough to supply variable number of samples to a 
microfluidic device without any modifications in the transport system or the device.  
The ‘plug-in cartridge’ technique developed by the Whitesides group(106) provides an 
elegant solution to the problem of introducing a large number of reagents on a 
microfluidic device through a single inlet. Under this approach, a series of sample plugs 
are loaded into a capillary, with air bubbles present between sample plugs acting as 
spacers. This capillary is connected to a microfluidic device, for serial delivery of these 
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sample plugs. However, in this approach, the sample plugs are constantly in contact with 
the capillary inner surface, leading to the problem of cross contamination between 
plugs(106). Another modification of this approach developed by the Ismagilov 
group(107) utilizes an immiscible carrier fluid instead of an air bubble to act as a spacer 
between sample plugs. The carrier fluid in this approach preferentially wets the inner 
surface of the capillary, thus preventing direct contact between sample plugs and the 
capillary surface. As a result, the problem of cross contamination between sample plugs 
is eliminated. The carrier fluids typically used for generating these sample plug arrays are 
fluorinated oils, which also reduce the problem of reagents leaking from sample plugs 
into the carrier fluid due to their low solubility for most reagents(107).  
Although this approach is promising, the current techniques used under this approach 
for generating the ‘sample plug cartridges’ have some issues which need to be resolved. 
The common technique of using a syringe pump for aspirating sample plugs from a 
sample well(99, 108, 109) in a multi-well plate can be extremely slow. Another technique 
of using vacuum for aspirating a sample plug can be much faster(106). However, this 
technique can only provide a maximum driving pressure of 1 atm (~15 psi). As a result, 
the driving force may not be sufficient to load large numbers of sample plugs into a 
capillary due to the increasing fluidic resistance of the capillary with the introduction of 
sample plugs. Furthermore, both these techniques require the free end of the capillary to 
be attached to either a syringe or a vacuum source, thus excluding the possibility of 
operating this sample loading system in sync with the operations on a downstream 
microfluidic device. This can be a major setback to throughput as the possibility of 
conducting assays in continuous flow manner on microfluidic devices, as has been 
demonstrated earlier(110), is precluded.  
To overcome these issues, we conceptualized and fabricated a sample plug loading 
system, which utilizes positive pressure for loading sample plugs from an industry 
standard multi-well plate to a capillary. Fig 6.10 shows a schematic illustrating the 
working principle of this system. A critical component of this system is a ‘capillary 
adapter’ which acts as an interface between a capillary, to be used for holding the sample 
plug array, and a multi-well plate used for holding samples. As shown in the schematic, 
the capillary adapter can be sealed with a sample well on the multi-well plate, creating a 
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temporary pressure chamber in the sample well. In this sealed mode, the capillary 
attached to the capillary adapter is immersed in the sample present in the well. The 
pressure input on the capillary adapter can then be used to apply pressure to the sample in 
the well for a controlled amount of time. As a result, a small plug of sample is pushed 
from the well into the capillary. The size of this plug can be controlled by varying the 
input pressure and the pressure application time. Repeating this process with multiple 
sample wells can be used to generate an array of sample plugs in the capillary. As is clear 
from Fig 6.10, this whole sample plug loading process only requires one end of the 
capillary to be engaged, while the other end of the capillary is free to be interfaced with a 
downstream microfluidic device, where further operations can be carried out with the 
sample plug array.  
Fig 6.11 shows a detailed model of the capillary adapter we designed in the CAD 
software ‘Solidworks’ (Solidworks Corp.). The wider backside of the adapter with the 
three large holes is used to bolt the capillary adapter to a stable support. The narrower 
front side is the actual functioning head of the capillary adapter. The functioning head 
consists of three disc shaped recesses on three sides (top, left and right), which are used 
to seat three NanoPorts (Idex Health and Science). The NanoPorts can be used to make a 
leak free connection with different types of tubing. The NanoPort on the top side is used 
to attach the capillary to the capillary adapter. The NanoPort on left side is used to attach 
the pressure supply line to the capillary adapter, while the NanoPort on the right side can 
be used to gauge pressure in the sample well, if required. All these NanoPorts holding 
locations on the capillary adapter have holes drilled in the center and routed to the bottom 
of the capillary adapter, as shown in the bottom view (Fig 6.11). When in use, the 
capillary goes through the straight hole drilled from the top of the capillary adapter to the 
bottom side. The bottom side of the capillary adapter has a disc shaped recess and a 
protruding circle. The disc shaped recess holds a silicone sealing ring, which is used to 
temporarily seal the capillary adapter with a sample well on a 96-well plate. The 
protruding circle acts as a centering feature, which is used for centering the capillary 
adapter into a sample well.  
Our assembled Serial Sample Loading (SSL) platform is shown in Fig 6.12. All the 
components of the SSL platform are attached to an aluminum breadboard for support. A 
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vertical stainless steel post bolted to the aluminum breadboard provides strong support 
structure for the capillary adapter. The capillary adapter is bolted to an angle bracket, 
which can slide on the post. This assembly allows us to manipulate the height of the 
capillary adapter from the aluminum base, as required. The capillary adapter is fixed at a 
suitable height to leave sufficient space for an assembly for XYZ motion of a 96-well 
plate below it. To control the cost of the pilot system, we chose to keep the motion of the 
96-well plate in the XY plane manual by using simple rails. However, these rails can be 
easily replaced with a motorized XY stage for automated motion of the 96-well plate. 
Controlled motion of the 96-well plate in the Z dimension, however, is critical for 
providing a reproducible seal between the capillary adapter and a sample well. So the 
motion in the Z-dimension was motorized. Typical linear translation stages are ill-suited 
for this application due to the limitation on the load supported by these stages along the 
direction of travel. Hence, a Motorized Lab Jack was used for automated motion of the 
96-well plate in the Z dimension. Fig 6.12 also shows an Electronic Pressure Controller, 
which can control the pressure applied to a sample well through the capillary adapter. 
3.5.4.2 Materials and Methods 
The capillary adapter was designed in Solidworks (Solidworks Corp.) and then 
fabricated at the Physical Sciences Machine Shop at Johns Hopkins University. The 
capillary adapter was fabricated using stainless steel as substrate, to prevent corrosion 
due to contact with biological samples and buffers. All other structural components for 
the SSL system were purchased from Thorlabs (Newton, NJ). A Motorized Lab Jack 
(L490MZ/M, Thorlabs) was purchased to use for computer controlled vertical motion of 
the 96-well plate in the SSL system. The electronic pressure controller used with the SSL 
system was purchased from Alicat Scientific Inc. (Tucson, AZ). The pressure controller 
used is a dual valve pressure controller (PCD-100PSIG-D-PCV03), which eliminates the 
need for bleed ports and relief valves typically required for pressure control in a closed 
volume. NanoPorts (N-124H, N-333 and N-125H Idex Health and Science) were bonded 
to the capillary adapter at the three ports according to the instructions provided by Idex. 
The sealing ring attached to the bottom of the capillary adapter was fabricated using a 
silicone septum (Corning). The ring shape was punched out of the silicone septum using 
70 
 
hole punches (3/8” and 13/64” hole diameter, McMaster). The capillary adapter was 
designed to be compatible with Costar 96-well plates (Corning). The Motorized Lab Jack 
and the Electronic Pressure Controller were interfaced with a computer through USB 
ports. Custom software written in LabVIEW (National Instruments), allowed us to 
control the motion of the 96 well-plate in the vertical direction, as well as the pressure 
applied to a sample well through the capillary adapter.  
The sample loading experiments were conducted using Silica Capillary Tubing 
(Polymicro Technologies). The capillaries were treated with AquapelTM (PPG 
Industries) before an experiment, to render the inner surface of the capillary hydrophobic. 
The samples used for most experiments were food dyes (Ateco, Glen Cove, NY), unless 
specified otherwise. The carrier fluid used for separating sample plugs from each other 
was a mixture of FC-3283 (3M) and 1H,1H,2H,2H-Perfluoro-1-octanol (Sigma-Aldrich 
Co.) in the ratio of 8:1 by volume. For these experiments, the Aquapel treated capillary 
was completely filled with the carrier fluid first. Following this, a sample well on the 96-
well plate was manually aligned with the capillary adapter. The LabVIEW software then 
raised the 96-well plate in vertical direction, to seal the sample well with the capillary 
adapter. The same software was then used to apply the desired pressure profile to the 
sample well for the desired amount of time. Following this, the 96-well plate was lowered 
by the LabVIEW software. We then manually aligned another well containing the carrier 
fluid with the capillary adapter. The same sample plug loading steps were then used to 
load a carrier fluid plug into the capillary. This alternating sequence of sample and carrier 
fluid plug loading was repeated until the desired number of sample plugs was loaded into 
the capillary. For the experiments which required sample plug volume estimation, we 
used a 1 m long silica capillary with a 200 μm inner diameter (ID). The sample used for 
these experiments was a single food dye. A series of 12 sample plugs separated by carrier 
fluid was loaded into the capillary using the steps described above. This capillary was 
then placed on the white background of a ‘letter’ sized sheet of paper and imaged using a 
Digital Single-Lens Reflex (DSLR) camera. The camera was placed such that the whole 
letter sized paper was included in the camera’s field of view. The image was then 
imported in ImageJ (104) for plug volume estimation. Length scale was set in the image 
using the known length of the letter sized sheet of paper. Following this, the length of 
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each sample plug was measured by manually drawing a line marking the length of the 
plug in ImageJ. This measured length, along with the known cross sectional area of the 
capillary was then used to estimate the plug volume for each sample plug. The plug 
volume data from the last 10 sample plugs for each loading condition was then used for 
the data analysis. 
3.5.4.3 Results 
One of the first critical tests of our SSL platform was to determine its capability to 
provide significantly higher driving pressure than vacuum (~15 psi) for sample plug 
loading in a capillary. To conduct this test, we first attached a silicone sealing ring to the 
capillary adapter, as described in the ‘Materials and Methods’ section. The NanoPorts for 
the capillary and pressure gauge on the capillary adapter were plugged using plugs (Idex 
Health and Science). The electronic pressure controller was connected to an input 
pressure supply of 95 psi from a Nitrogen cylinder. A sample well on a Costar 96-well 
plate, was then sealed with the capillary adapter using the SSL system. The LabVIEW 
software was then used to raise the pressure in the sealed sample well to different peak 
pressure values (10, 20, 30, 40 and 50 psi). Fig 6.13 shows a plot of the pressure in the 
sample well, sensed by the pressure controller, for these 5 different tests. The pressure 
plot for each test consists of 3 distinct regions: Rising phase (the pressure in the sample 
well is raised from zero to peak value during this phase), Peak pressure phase (pressure in 
the sample well is maintained at peak value during this phase) and Decline phase 
(pressure in the sample well is reduced from peak to zero psi during this phase). The 
duration of each of these phases can be controlled using the LabVIEW software. All 
these phases were fixed at duration of 5 sec each for the plots shown in Fig 6.13. The 
pressure plots demonstrate that the pressure controller can easily maintain a peak pressure 
of 50 psi in the sealed sample well as commanded. Thus, proving that our SSL system 
can provide substantially higher driving pressures than a vacuum based system for 
sample plug loading in a capillary. The pressure controller we used was factory calibrated 
to a maximum pressure of 50 psi. Hence, we couldn’t test the SSL system for pressures 
higher than 50 psi. Furthermore, Fig 6.13 also demonstrates that the pressure controller 
can control the timing of the ‘Rising’ and ‘Peak pressure’ phases very precisely. The 
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duration of the ‘Decline’ phase, however, being a passive process driven by the pressure 
difference between the sealed sample well and the atmosphere, depends to some extent 
on the peak pressure value.  
We then tested the capability of the SSL system to load a series of sample plugs into a 
capillary. Initial testing was conducted using food dyes as samples for easy visibility. A 
silica capillary was loaded with alternate plugs of different food dyes and carrier fluid 
using the SSL system. Fig. 6.14a shows a micrograph of the silica microcapillary with a 
few food dye sample plugs. The micrograph shows excellent uniformity of plugs, the 
ability of the SSL system to keep sample plugs separate from each other, as well as the 
capability to load sample plugs without breakup into the capillary. We then tested the 
sample plug loading scheme with a biologically relevant sample in the form of a 
‘PicoGreen’ (Life Technologies) stained Lambda DNA (Promega) sample. The Lambda 
DNA was present at a concentration of 2ug/ml concentration in the sample. Biological 
samples provide additional challenge to the sample plug loading process due to the lack 
of any visual feedback during sample plug loading. Food dyes are easily visible and their 
plug uniformity can be easily discerned during the loading process. However, most 
biological samples being transparent, it is difficult to differentiate them from the 
transparent carrier fluid. The variation in plug size is solely dependent on the 
repeatability of the SSL system. We thus loaded these Lambda DNA sample plugs into a 
silica capillary essentially blindly and then obtained a fluorescence image (Fig. 6.14b) of 
the silica capillary using a Typhoon 9410 Variable Mode Imager (GE Healthcare). The 
fluorescent Lambda DNA plugs can be clearly seen over the dark background of the 
interspersed carrier fluid plugs. Excellent uniformity of plug loading, despite lack of 
visual feedback is also clearly evident from this image. The ultimate purpose of the SSL 
system is delivery of a large array of sample plugs to a microfluidic device for further 
processing. So, as a proof of principle, we also demonstrated interfacing of a capillary 
with a simple microfluidic device (Fig. 6.14c). A series of sample plugs made from food 
dye using the SSL system, were then delivered from the capillary to the microfluidic 
device. Excellent transition of sample plugs from the capillary to the microfluidic device 
without break-up can be clearly seen from the image in Fig. 6.14c.  
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We then conducted more rigorous testing of the SSL platform to determine its 
capability to maintain sample plug uniformity, as well as control the sample plug size as 
desired. To conduct these experiments, we loaded a series of twelve sample plugs made 
of the same food dye into a 1m long silica capillary for each set of sample plug loading 
conditions, as described in the ‘Materials and Methods’ section. The sample plug volume 
estimated from the last ten sample plugs was used to estimate the mean and standard 
deviation of the plug volume for each loading condition. These values were then used for 
the plots shown in Fig. 6.15 and 6.16. The sample plug volume depends on a few factors: 
1) Peak pressure (Ppeak) applied, 2) duration of the ‘Rising’ and ‘Decline’ phases of 
pressure application and 3) the duration (Tpeak) of the Peak pressure phase. All these 
parameters can be precisely controlled in the SSL system with our LabVIEW software. 
We decided to vary the intuitive factors like Ppeak and Tpeak to control the sample plug 
volume. Initially, we held Ppeak constant and varied Tpeak to estimate the sample plug 
volume generated for different Tpeak values. This experiment had two objectives: First to 
estimate the variation in plug volume for a fixed set of loading conditions and second to 
estimate the relationship between plug volume and Tpeak for a fixed value of Ppeak. Fig. 
6.15 shows a plot of sample plug volume vs Tpeak for three different values of Ppeak 
(0.5, 1 and 1.5 psi). The linear relation between plug volume and Tpeak for each 
individual Ppeak value demonstrates the capability of the SSL system to precisely control 
the plug volume in a predictable manner, through the variation of the duration of the 
‘Peak pressure’ phase. Furthermore, the plug size variation indicated by the error bars is 
fairly low with a maximum coefficient of variation of approx. 7% for all but two smallest 
plug volumes generated, where we were approaching the lower limit of the operation of 
the electronic pressure controller. We expect the system performance, in terms of plug 
volume variability, to improve as the motion of the 96 well plate is automated in the 
horizontal plane too, as the overlap of the sample well wall with the sealing ring of the 
capillary adapter can be reproduced across the area of the 96 well plate, providing a 
reproducible seal for every single sample plug loading step.  
Varying Tpeak to control plug volume can be beneficial for smaller plug volumes. 
However, as the plug volume increases, Tpeak can quickly increase, reducing the speed 
at which sample plugs can be loaded in a capillary. For larger plug volumes, it would be 
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beneficial to raise the peak pressure, to achieve larger plug volume in the same amount of 
time. Fig 6.16 shows a plot of the sample plug volume vs Ppeak for a fixed value of 
Tpeak (1 sec). This plot shows another linear relationship between sample plug volume 
and Ppeak, providing an alternative predictable way to vary the sample plug volume 
through variation of the peak pressure applied to the sample well. The value of Ppeak 
here is only limited by the pressure at which the seal between the sample well and the 
capillary adapter breaks down. This result, thus illustrates a limitation of applying 
vacuum to load sample plugs in a capillary, which can be overcome with the use of the 
SSL system. Although, the vacuum level can be controlled with a regulator, the driving 
pressure cannot be greater than 1 atm(~15psi), limiting the speed at which large sample 
plugs can be loaded in a capillary.  
One limitation of the SSL system is its dependence on the fluidic resistance of the 
capillary for maintaining the uniformity of sample plug volume for the same sample plug 
loading conditions. However, as more and more sample plugs are loaded into the 
capillary, the fluidic resistance of the capillary increases, gradually reducing the sample 
plug volume over the course of loading of sample plugs. This effect is illustrated in Fig 
6.17a. In this figure, the sample plug volume data is normalized by the plug volume of 
the first sample plug generated for each loading condition. The normalized sample plug 
volume is then plotted against the sample plug number in the loading sequence. As seen 
from the plot, for three independent loading conditions (Ppeak: 1 psi, Tpeak: 1.5, 2 and 
2.5 sec), we observe a consistent gradual reduction in the sample plug volume as the 
number of sample plugs in the capillary increases.  
This problem can be avoided through pressure compensation for the changing fluidic 
resistance of the capillary. We observed the sample plug volume reduce by approx. 15% 
for the 10th sample plug loaded into a capillary for all the three conditions shown in Fig 
6.17a. So we did simple linear peak pressure (Ppeak) increase for each sample plug in the 
loading sequence to compensate for the 17% (1/0.85) increase in the fluidic resistance 
over the course of loading 10 sample plugs in the capillary. The normalized sample plug 
volumes for this modified loading scheme with the same starting point as the three 
conditions shown in Fig 6.17a, are plotted in Fig 6.17b. These plots demonstrate that a 
simple compensation scheme can avoid gradual reduction in sample plug volume with 
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increasing number of sample plugs, further improving the sample plug uniformity of the 
SSL system. In the future versions of the SSL system, the compensation scheme can be 
further improved by devising a mathematical model of the changing fluidic resistance in 
the capillary and incorporating it in the LabVIEW software, to automatically compensate 
for the changing fluidic resistance by varying the peak pressure (Ppeak) applied to the 
sample well for each consecutive sample plug being loaded into the capillary. 
Alternatively, an imaging based technique can be used to detect the appearance of the 
edge between a sample plug and the carrier fluid at a particular distance from the end of 
capillary immersed in the sample solution, to provide feedback for computer control of 
the pressure controller. This approach can enable very accurate metering of sample plug 
volume for each sample plug despite changing fluidic resistance in the capillary. 
3.5.4.4 Discussion 
In conclusion, we have devised a new technique for serial delivery of a large number 
of samples to a microfluidic device, directly from a standard multi-well plate. Our SSL 
system differs from similar techniques developed by other research groups in the past, in 
the application of positive pressure as a driving force for the loading of a series of sample 
plugs into a capillary for direct delivery to a microfluidic device. The SSL system can be 
used for rapid sample plug loading into a capillary with the only rate limiting step being 
movement of the multi-well plate, to load samples from different sample wells. We 
demonstrated the functioning of the SSL system as well as its capability to precisely 
control the sample plug volume. Since the SSL system engages only one end of the 
capillary in sample plug loading, it can be directly interfaced with a downstream 
microfluidic device for its operation in synchronization with the microfluidic device. In 
its current form, the SSL system was designed for loading sample plugs into a single 
capillary. However, the design can be easily extrapolated for simultaneous loading of 
sample plugs in multiple capillaries from a row of sample wells. We expect the SSL 
system to be instrumental in further improvement in the throughput of droplet-based 





 Enhancing Throughput of Combinatorial 4
Droplet Devices via Droplet Bifurcation, 
Parallelized Droplet Fusion, and Parallelized 
Detection  
 
Combinatorial droplet microfluidic devices with programmable microfluidic valves 
have recently emerged as a viable approach for performing multiplexed experiments in 
microfluidic droplets. However, the serial operation in these devices restricts their 
throughput. To address this limitation, we present a parallelized combinatorial droplet 
device that enhances device throughput via droplet bifurcation, parallelized droplet 
fusion, and parallelized droplet detection. In this device, sample droplets split evenly at 
bifurcating Y-junctions before multiple independent reagent droplets are injected directly 
into the split sample droplets for robust droplet fusion. Finally, the fused sample and 
reagent droplets can be imaged in parallel via microscopy. The combination of these 
approaches enabled us to enhance the throughput by 16-fold – with ready potential for 
further enhancement – compared to traditional, serially-operated combinatorial droplet 
devices. Given its current performance and prospect for future improvements, we believe 
the parallelized combinatorial droplet device has the potential to meet the demand as a 





Recent years have seen the emergence of microfluidic droplet technology in a variety 
of chemical and biochemical applications [115] ranging from single-cell analysis [70, 
116, 117] to enzyme kinetics measurements [118, 119] and even nanoparticle synthesis 
[120, 121]. In particular, microfluidic droplets have proven pivotal in digital analysis of 
individual biological samples at the single-molecule level [59, 67, 122, 123]. While this 
technology offers the capacity to divide a homogeneous reaction (i.e., one sample against 
one set of reagents) into a large number of reactions in droplets, it nevertheless faces 
challenges in generating a large combination of sample-reagent mixtures in a multiplexed 
manner. And although approaches such as integrated picoinjectors [105, 124], segregated 
microfluidic plugs in tubing [104, 106, 107, 125], and multiple devices [69] have been 
demonstrated to improve the multiplexing capacity of microfluidic droplet platforms, 
there remains a critical need for alternative approaches that facilitate multiplexed 
experiments in droplets. 
As a promising alternative, droplet microfluidic devices that utilize programmable 
microfluidic valves to mix combinations of samples and reagents on-demand [62, 108, 
126-130] presents a viable approach to performing multiplexed experiments in 
microfluidic droplets. For example, such devices have been employed to demonstrate 
multiplexed experiments such as the detection of DNA [128, 130] and characterization of 
matrix metalloproteases[127, 130]. Importantly, in some of these devices, the 
conservation of positional order of each droplet after combinatorial assembly enables 
spatial indexing as an effective means to track droplets [62, 130]. Unfortunately, a key 
limitation to this platform is its throughput. Because the combinatorial droplets are 
generated sequentially and serially, the rate of analysis is limited by the rate at which 
droplets can be assembled and detected in the order of assembly (Figure 1A). A design 
that can increase the throughput of such microvalve-based combinatorial droplet devices 
is therefore needed. 
To address this limitation, we have developed a parallelized combinatorial droplet 
device design. This design is achieved via droplet splitting [131-137], parallelized droplet 
fusion, and parallelized droplet detection (Figure 1B). Specifically, each sample droplet 
first travels through bifurcating Y-junctions (two stages as shown here) and split into 
identical daughter droplets (four as shown here) before each daughter droplet is fused 
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with its designated reagent. Importantly, the reagents can be simultaneously injected into 
the daughter droplets, thereby facilitating improved throughput. Finally, the entire group 
of fused sample-reagent droplets originating from the single sample droplet can be 
detected in parallel, further enhancing the throughput. To demonstrate this concept, we 
designed and fabricated a parallelized combinatorial droplet device and showed that the 
new design can improve the device throughput by 16-fold – with ready potential for 
further enhancement – when compared to a traditional, single-channel design. 
 
4.2 Experimental Section  
4.2.1 Mask Design and Printing  
Fluidic and valve layer masks were designed in L-Edit v16.0 (Tanner EDA, Monrovia, 
CA). To account for polydimethylsiloxane (PDMS) shrinkage during the soft lithographic 
molding step (see Master Mold Microfabrication section), features on the valve layer 
mask were expanded by 1.5% in both dimensions. Mask patterns were printed onto high-
quality transparencies at 20000 dpi by CAD/Art Services, Inc. (Bandon, OR). 
Transparency masks were mounted on five-inch soda lime glass mask holders (HTA 
Enterprises, San Jose, CA) and stored in clean room environment prior to use.  
4.2.2 Master Mold Microfabrication  
Master molds for both fluidic and valve layers of the PDMS chip were microfabricated 
via standard photolithography techniques. Fluidic and control layer molds were 
fabricated on four-inch silicon wafers (Polishing Corporation of America, Santa Clara, 
CA). Prior to processing, all wafers underwent a dehydration bake at 200 °C for at least 
two hours. Our device design involves regions with two different channel heights. 
Shallow channels fabricated with SPR-220-7 (positive photoresist; Microchem Corp., 
Newton, MA) are incorporated near the sample introduction region and reagent inlets to 
allow for valve actuation. The height of these channels is ~25 µm and these can be 
collapsed by applying pressure to the control layer. This layer was patterned using 
photolithography and hard baked to generate a rounded channel cross section, as required 
for effective valve closure [138]. This was followed by patterning of SU8-3025 
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(Microchem Corp., Newton, MA) to generate the rest of the fluidic channel network 
(height was ~45 µm) on the fluidic mold. For the valve control mold, a single layer of 
SU8-3025 was patterned on the wafer (height was ~45 µm). 
4.2.3 Microfluidic Chip Fabrication  
The microfluidic devices were fabricated using multilayer soft lithography techniques  
[139]. A modified three-layer fabrication process was developed [62, 127]. We used 
SYLGARD 184 Silicone Elastomer Kit (Dow Corning, Midland, MI) for fabricating our 
chips. Prior to use, fluidic layer molds were silanized using vapor deposition of 
chlorotrimethylsilane (Sigma-Aldrich, St. Louis, MO) for at least 15 minutes to minimize 
adhesion between PDMS and the patterned structures on the wafer. For this modified 
fabrication process, three different batches of PDMS were mixed. These varied in 
composition, and base to crosslinking agent ratios of 15:1, 10:1 and 6:1 were used, 
respectively. PDMS was degassed for approximately 30 minutes before pouring on the 
respective molds. The control layer mold was spin coated with a thick layer (~1 mm) of 
6:1 PDMS and baked at 80 °C for 5 min. A thin layer of 15:1 PDMS was spin coated on 
the fluidic layer mold at 1300 RPM for 1 min. The device was designed such that the 
valve regions on the device were placed in areas surrounded by shallow fluidic channels, 
ensuring uniform coverage of these regions with a thin layer of PDMS. The PDMS on the 
fluidic layer mold was then baked at 80 °C for 4 minutes. The PDMS was removed from 
the control layer mold, cut to match the size of the fluidic layer, and aligned with baked 
PDMS layer on the fluidic layer mold under a stereoscope. The fluidic layer mold with 
the aligned control layer was baked at 80 °C for 5 min to promote adhesion between the 
control layer and the fluidic layer. Following this, 49.5 g of 10:1 PDMS was poured on 
the fluidic layer mold, covering all features on the fluidic layer mold with a 3-4 mm thick 
layer of PDMS. The fluidic layer mold was then baked for at least 20 minutes at 80 °C. 
Following this, the PDMS was removed from the fluidic layer mold and individual 
devices were cut. Fluidic access holes were punched into individual chips with sharpened 
needles (20 gauge; McMaster-Carr, Elmhurst, IL), bonded to thickness #1 cover glasses 
(24 mm × 60 mm, thickness = ~0.13 to 0.16 mm; Ted Pella, Inc., Redding, CA) 
following O2 plasma treatment (30 W, 500 mTorr, 45 s), and immediately baked at 80 °C 
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for at least 5 min to finalize device fabrication. All devices were subsequently treated 
with Aquapel (Pittsburgh Glass Works LLC, Pittsburgh, PA) to render their surface 
hydrophobic and fluorophilic [38]. Aquapel-treated devices were then dried at 80 °C for 
at least 1 hour prior to use. 
4.2.4 Experimentation  
A set of solenoid valves was used to control the on/off status of the individual 
microvalves in the microfluidic device. Connections between solenoid valves and 
microvalves were established via water-filled Tygon® microbore tubing (0.02-inch ID 
and 0.06-inch OD; Cole-Parmer, Vernon Hills, IL) with 23-gauge blunt needles 
(McMaster-Carr) inserted at designated valve holes. Microvalves were typically 
pressurized at ~40 psi. Valve operation sequences were programmed and controlled by 
custom software written in MATLAB (MathWorks, Natick, MA). This software allowed 
us to execute a predetermined sequence of valve actuation with independent time control 
for each actuation. The opening of a valve corresponding to an input on the device led to 
the injection of a sample fluid from that inlet into a central channel on the device. The 
volume of this droplet could be precisely controlled through variation of the opening time 
of the valve as well as the back pressure [62].  
The carrier oil used to maintain the separation between sample plugs consisted of a 
perfluorocarbon FC-40 (3M, Two Harbors, MN) and a nonionic fluorous-soluble 
surfactant 1H, 1H, 2H, 2H-Perfluoro-1-octanol (Sigma-Aldrich) (4:1 v/v). The carrier oil 
was loaded into Tygon microbore tubing and connected to the device via the designated 
oil inlet. Prior to generation of sample and reagent droplets, the carrier oil was injected to 
fill and prime the entire central fluidic channel. The testing of our platform was 
performed using a PCR buffer (1× Gold PCR buffer; Thermo Fisher Scientific, Waltham, 
MA) and food dyes (Ateco, Glen Cove, NY) as surrogates for different samples and 
reagents in order to enhance visualization. All samples and reagents were loaded into 
PTFE tubing (30 AWG; Cole-Parmer) and connected with the device through their 
designated inlets. All reagent input channels on the device were primed with the 
respective reagent. Any residual reagents in the central carrier fluid channel following 
this process were flushed out using the carrier oil. All the inputs on the device were kept 
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under constant pressure, with separate input pressures for the carrier oil (10 psi), sample 
inlets (5 psi), and all four reagent inputs (3 psi). 
4.2.5 Data Acquisition and Analysis  
Droplet generation, bifurcation, and fusion were observed with an inverted microscope 
(IX71; Olympus Corp., Japan) with either a 1.25× magnification objective lens (Olympus 
PlanAPO N 1.25×/0.04NA) or a 4× magnification objective lens (Olympus UPlanFl 
4×/0.13NA). A digital single-lens reflex (DSLR) camera (EOS 60D; Canon, Inc., Japan) 
that was mounted on the microscope and interfaced via EOS Utility software was used to 
take images and videos of device operation. Screenshots were taken from videos via VLC 
media player (VideoLAN). Images were imported in ImageJ [140] and processed using 
its built-in functions. The area of the droplet was measured via the “Threshold” and 
“Analyze Particles” functions in ImageJ. Dusts and shadows on the images, which did 
not affect the generation, bifurcation, and fusion of droplets were digitally removed via 
Adobe Photoshop. Furthermore, the tone and the contrast of the images were also 
enhanced via Adobe Photoshop. 
 
4.3 3. Results 
4.3.1 Device Design and Workflow  
We have designed a microfluidic device to support parallelized combinatorial droplet 
workflow (Figure 2). The microfluidic device employs a two-layer architecture where the 
flow of oil, sample droplets, and reagent droplets in the fluidic layer (Figure 2, blue) is 
regulated by designated microvalves in the valve layer (Figure 2, red). The fluidic 
channel – where the droplet generation, bifurcation, fusion, and detection occur – 
undergoes several splits, connects with reagent inlet channels, and eventually divides into 
16 channels with the same length and hence the same fluidic resistance. The most 
upstream inlet is reserved for the carrier oil, which drives all flow on the device. 
Downstream to the oil inlet are two sample inlets with corresponding rinsing channels 
(Figure 2, insert micrograph 1) connected to the central carrier oil channel. Two pressure 
relief channels near the sample inlets ensure the uniformity of sample droplets by 
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decoupling droplet generation from fluidic resistance of the incubation channel. The 
central carrier oil channel splits into two identical halves at a bifurcating Y-junction 
(Figure 2, insert micrograph 2). For all four stages of bifurcation Y-junctions, the angle is 
45° and the two outgoing channels shrink in width by a factor of √2 (e.g., for the first 
stage of bifurcating Y-junction, the single incoming channel has a width of 200 µm and 
each of the two outgoing channels has a width of 140 µm) [133, 134]. After the first two 
stages of bifurcation, each of the four resulting fluidic channels is connected with a 
reagent channel that is individually controlled by a microvalve for programmable reagent 
injection (Figure 2, R1 – R4; insert micrograph 3). Importantly, in the general reagent 
injection area, the cross-section of fluid channels are designed such that the sample 
daughter droplets can be elongated to be several-fold longer than the width of the reagent 
inlet channel. As such, reagents can be directly injected into the sample droplets and 
fused, removing the need for droplet synchronization. Each fluidic channel subsequently 
goes through two additional bifurcating Y-junctions, resulting in 16 serpentine incubation 
channels to accommodate four replicates of the four different reaction conditions. 
Leveraging droplet splitting to produce replicates, which is important in all biochemical 
experiments, obviates serially generating replicates and thus enhances device throughput. 
All incubation channels are designed to have the same length to ensure equal fluidic 
resistance, which is critical for droplet uniformity. Finally, at the detection zone, the pitch 
between adjacent channels decreases to 50 µm such that all 16 50-µm-wide incubation 
channels can be viewed within a microscope viewing area (using a 4× objective lens), 
thus facilitating parallel detection via microscopy (Figure 2, insert micrograph 4). 
In our device, droplet bifurcation and subsequent parallelized reagent injection, 
droplet fusion, and droplet detection are performed in a streamlined workflow to 
maximize the throughput. Here, all microvalves are kept under positive pressure so that 
they are normally closed; they are opened on-demand to achieve injection. The carrier 
oil, samples, and reagents are pre-loaded into their designated inlets and are kept under 
constant pressure, so that when microvalves are opened, these fluids can be injected to 
form and subsequently maneuver droplets. Sample droplets are first generated by briefly 
opening the sample microvalve, and upon closing the sample microvalve and opening the 
oil microvalve, are pushed through the first two stages of bifurcating Y-junctions, 
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producing a total of four identical daughter droplets. As the sample droplets flow through 
the reagent injection region, the four reagent microvalves are opened momentarily to 
inject reagents directly into elongated sample daughter droplets and achieve droplet 
fusion. Fused sample-reagent droplets go through two additional bifurcating Y-junctions 
such that each injection of sample and reagents results in a total of 16 droplets (four 
replicates of four different conditions). Each daughter droplet then flows through its 
serpentine incubation channel and arrives simultaneously with all other daughter droplets 
in the same group at the detection zone, thus facilitating parallel detection via microscopy 
(see Supplementary Video S1). Notably, the volume of fused droplets is controlled to 
span the cross-section of all fluid channels, as this is critical to maintain the spatial 
indices of all droplets.  
4.3.2 Uniform Droplet Splitting  
We have achieved uniform droplet splitting in our device, which is a critical 
prerequisite to the parallelized operation of our device. To demonstrate this, we generated 
a series of droplets (volume = ~10 nL; frequency = 0.5 Hz) with black food dye as the 
sample because this dye produces sharp color contrast and is empirically found to travel 
through the device with minimal sticking, and thus facilitates downstream operation and 
analysis. We then allowed them to travel downstream and continuously bifurcate through 
four stages of bifurcation Y-junctions. By recording videos of droplet splitting at all Y-
junctions and extracting screenshot images from the videos, we clearly observed droplets 
splitting into two even halves as they flow through a bifurcation Y-junction (Figure 3A). 
To quantitatively analyze the bifurcation performance across the four bifurcation stages, 
we used image analysis software to measure the areas of the pair of split droplets after 
splitting at each of the 15 Y-junctions and calculated the ratio of the area of each droplet 
over the combined area. As such, an area ratio of 50% for both daughter droplets 
indicates even droplet splitting. The area ratio of daughter droplets at the four different 
stages and the 15 Y-junctions consistently remained at ~50% (Figure 3B; n = 10 for each 
Y-junction), indicating uniform droplet splitting. Furthermore, uniform droplet 
bifurcation across the different stages of Y-junctions validates that Y-junctions enable 
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uniform droplet splitting even with different Y-junction channel dimensions and droplet 
volumes.  
Of note, in order to achieve uniform droplet splitting, it is critical to maintain the same 
fluidic resistance across all fluidic channels that flow in parallel. Here, we have carefully 
examined our devices to ensure the fluid channels are free of obstructions due to defects 
in the master mold. We have also found a potential source for severely increasing the 
fluidic resistance of a particular fluid channel is an overlaying valve control channel, as 
that may cause the fluid channel to sag down and increase the fluidic resistance. In our 
design, we have avoided overlaying valve control channels on top of fluid channels. For 
the only occurrence, we designed the valve control channel to overlay the four fluid 
channels equally, and we narrowed the valve control channel to prevent it from sagging 
into the fluid channels. Finally, we have designed filter structures at all sample and 
reagent inlets to prevent channel clogging, which can also severely increase the fluidic 
resistance of a particular fluid channel and disrupt droplet splitting.  
4.3.3 Parallelized Injection of Reagents with Individualized Calibration  
We have designed our device to simultaneously inject multiple reagents in parallel. To 
demonstrate this capability, we pre-loaded each reagent inlet with a different color of 
food dye (orange, green, blue, and black in this case) and simultaneously actuated the 
microvalves that control the reagent inlets to form four reagent droplets in parallel. 
Indeed, a simultaneous actuation of all four reagent microvalves resulted in four 
independent reagent droplets in their respective channels (Figure 4A).  
Importantly, the individually controlled reagent inlets in our device allow us to 
calibrate each inlet independently and to ensure consistent and accurate volume injection 
across parallel reagent channels. This design feature is important because the microvalves 
in our device, which are based on PDMS membranes, can vary in thickness as a result of 
the soft lithography fabrication process. Moreover, variations in reagent viscosity can 
lead to variability in droplet sizes as well [141, 142]. To show that we can use our 
individually addressable reagent inlets to correct reagent droplets that may have different 
sizes due to the aforementioned differences, we deliberately used four different colors of 
food dye (orange, green, blue, and black) as the reagents. When the four reagent 
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microvalves were opened with an identical opening time (e.g., 30 ms), the four resulting 
droplets could differ by as much as 44% in normalized droplet area (Figure 4B). Based 
on visually observing the initial size of the reagent droplets, we subsequently shortened 
or lengthened the opening time for each reagent microvalve. With such simple 
adjustments, we were able to generate reagent droplets with significantly improved 
uniformity; the variation in normalized droplet area reduced to < 12% (Figure 4C). 
Further improvements in the uniformity could be achieved by performing a few iterations 
of measuring the droplet areas via image analysis before fine-tuning the microvalve 
opening time. 
4.3.4 Reliable Droplet Fusion in Parallel  
Having demonstrated uniform droplet splitting and uniform reagent injection in 
parallel, we subsequently combined these two functions and demonstrated robust, 
parallelized fusion of sample and reagent droplets. We first confirmed reliable droplet 
fusion visually and qualitatively by using a polymerase chain reaction (PCR) buffer as 
the sample (due to its clear color and negligible sticking to the device) and four different 
colors of food dye as the four reagents. Here, we generated a series of sample droplets at 
~0.25 Hz and moved them through the first two bifurcation stages. Importantly, our 
design enforced an elongated shape for each of the four bifurcated daughter droplets as 
they traveled past the four reagent inlets, thus allowing us to directly inject reagents into 
them for robust droplet fusion (Figure 5; also see Supplementary Video S2). Of note, we 
tuned the back pressure applied to the reagent inlets to prevent fission of sample droplets 
during reagent injection. In addition, our design gradually widened the channels 
immediately downstream to the reagent channels, which caused droplets to slow down 
following reagent injection and facilitated fusion of sample and reagent droplets that may 
not have fused at the time of reagent injection. 
Parallelized fusion of sample droplets and reagent droplets was observed to maintain 
an efficiency of nearly 100% in our device. We quantitatively evaluated the fusion 
performance in all four channels of our device by performing the same droplet fusion 
experiment but using only the black food dye as the reagent in all four reagent channels 
in order to minimize potential experimental variations due to the viscosities of different 
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food dyes. Using video and image analysis to evaluate the droplet fusion in all four 
channels, we defined droplet fusion efficiency as the ratio between fused droplets and all 
droplets after the fusion step. The fusion efficiencies were between 98.1% (n = 52), 
99.1% (n = 107), 99.1% (n = 107), and 94.5% (n = 55) for the four channels, indicating 
reliable droplet fusion. These results show that droplets could be reliably fused without 
having to pause momentarily at the reagent inlets. Such capacity for continuous yet 
reliable droplet fusion thus presents key feature for enhancing the throughput in our 
device.  
4.3.5 Parallelized Droplet Imaging  
We used microscopy to simultaneously image and hence analyze fused droplets in all 
16 incubation channels. This imaging approach for parallelized detection is facilitated by 
designing the detection zone of the device to fit within the field of view of microscopes 
(under 4× microscope objective lens). To show parallelized droplet detection, we 
generated multiple groups of 16 droplets (four replicates of the four sample-reagent 
combination) and imaged them at the detection zone. Here, due to uniform droplet 
splitting, uniform reagent injection, and robust droplet fusion, the 16 droplets in each 
group had uniform sizes. For example, the droplet sizes in group 1 had only an 8.0% 
standard deviation and remained uniformly sized in group 20, with a standard variation of 
6.6% (Figure 6). Importantly, the droplets traveled at relatively the same speed through 
their own incubation channels and thus allowed their spatial indices to be maintained. 
Indeed, for the droplets in group 1, we measured that the 16 droplets varied by only as 
much as 3.67 mm in position after traveling through the 100-mm-long incubation 
channels, equivalent to a 3.67% variation. For the droplets in group 20, the 16 droplets 
mostly maintained their positional orders relative to each other while the maximum 
difference in position was only 3.46 mm. We note that, because the detection area is only 
2.5 mm in length, we combined and aligned two screenshots in order to measure the 
position of all 16 droplets in each group. Nevertheless, these results showed that the 
droplets in the parallel detection area could indeed be tracked via spatial indexing.   
 
4.4 Discussion  
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The highly parallelized reagent assembly approach described in this work presents an 
alternative approach to device architecture for droplet microfluidics. Devices employing 
shear-flow droplet generation has capacity for extremely high throughput, but their 
limited capacity for in-line combinatorial assembly of reagents has confined their utility 
to simple, throughput-based applications such as digital PCR. Our parallelized design 
presents an alternative architecture with greater flexibility for reagent assembly, while 
demonstrating the potential for parallel processing to bridge the gap in throughput. For 
example, even operating under a conservative 0.25 Hz generation rate for sample 
droplets, which equates to a 4 Hz generation rate for fused sample-reagent droplets, a 
single parallelized combinatorial droplet device is capable of detecting nearly 0.35 
million fused droplets per day. As such, this device has the potential to meet the need for 
high-throughput screening applications. 
Maintaining balanced fluidic resistance across all fluidic channels in parallel is critical 
to robust long-term operation of our parallelized combinatorial droplet device. Increases 
in fluidic resistance in a single incubation channel may cause sample droplets to split 
unevenly at the first two stages of bifurcating Y-junctions and travel through these 
junctions at different speeds, which may subsequently disrupt droplet fusion and 
ultimately lead to operation failure. In this work, we have carefully removed potential 
sources for increasing the fluidic resistance in our devices, such as obstructions in fluidic 
channels and overlaying valve control channels. In addition, we observed that the reagent 
viscosity may also be important to device operation. For example, sample droplets that 
fused with a more viscous food dye tend to travel slower through the incubation channels 
when compared to those that fused with a less viscous food dye. Such differences can 
also lead to unbalanced fluidic resistance in the device. As such, implementing reactions 
involving reagents that vary in viscosities in the droplet format in our parallelized 
combinatorial droplet device may require additional characterization steps to ensure 
reliable operation.     
We envision several routes towards improving our device. For example, for proof of 
concept, we have only implemented two stages of bifurcation prior to parallelized 
injection of four reagents. In our future iterations of the device, we envision increasing 
the number of bifurcation stages to three or four and the number of reagent channels to 8 
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or 16. For each reagent channel, we can further implement multiple reagent inlets. Thus, 
with the two post-fusion bifurcation stages for droplet replication, we can effectively 
improve the overall throughput of combinatorial droplet devices by 64-fold and beyond. 
We also plan to integrate sample inlets of the device to our previously reported serial 
sample loading system [143] so that the device can accept an unlimited number of 
samples from multi-well plates. Temperature-controlled heaters can be readily appended 
to the incubation region of the device to enable a host of biochemical assays that require 
elevated temperatures. Finally, we can implement wide-view imaging [33] to increase the 
area of detection and hence the capacity for parallel detection of droplets in our device.  
 
4.5 Conclusions  
In summary, we present a parallelized combinatorial droplet device that enhances 
device throughput via droplet bifurcation, parallelized reagent injection, and parallelized 
droplet detection. We demonstrate that microfluidic droplets can split evenly at all Y-
junctions across all four bifurcation stages in our device. We also show that we can 
simultaneously inject four independent reagents into their respective channels with equal 
volume, which can only be done by adjusting the valve opening time of each 
individually-addressable microvalve. Furthermore, we validate that sample and reagent 
droplets can be reliably fused in a continuous manner, which further enhances the device 
throughput. Finally, the fused sample and reagent droplets maintain their spatial indices 
and can be imaged in parallel via microscopy. Taken together, we have successfully 
parallelized the once-serial operation in combinatorial droplet devices and have improved 
the device throughput by 16-fold. Given its current performance and prospect for future 
improvements, we believe the parallelized combinatorial droplet device has the potential 
to meet the demand as a flexible and cost-effective tool that can perform high throughput 
screening applications.  
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Figure 4.1. Improving Throughput of Combinatorial Droplet Devices via Parallelization.  
(A) In the traditional design, sample droplets (S) are fused with designated reagents (R1 – R4) one at a time to generate 
the train of combinatorial droplets (S + R1, etc.), which maintain their spatial index within the single channel before 
they are sequentially optically detected. (B) The current design leverages parallelized operation via droplet bifurcation, 
parallel reagent injection, and parallel detection to improve the throughput. Specifically, each sample droplet first 
travels through bifurcating Y-junctions (two stages as shown here) and split into identical daughter droplets (four as 
shown here) before each daughter droplet is fused with its designated reagent via direct injection. Importantly, the 
reagents can be simultaneously injected into the daughter droplets, thereby facilitating improved throughput. Finally, 









Figure 4.2. Parallelized Combinatorial Droplet Device.  
The microfluidic device employs a two-layer architecture where the flow of oil, sample droplets, and reagent droplets 
in the fluid layer (blue) is regulated by designated valves in the valve layer (red). The most upstream inlet is reserved 
for the carrier oil, which drives droplet formation and flow. Downstream to the oil inlet are two sample inlets with 
corresponding rinsing channels (insert micrograph 1) connected to the fluid channel. The fluid channel splits into two 
identical halves at a bifurcating Y-junction and each of the four resulting fluid channels is connected with a reagent 
channel that is individually controlled by a microvalve for programmable reagent injection (R1 – R4; insert micrograph 
2). In our device, reagents can be directly injected into the sample droplets and fused, removing the need for droplet 
synchronization. Each fluid channel subsequently goes through two additional bifurcating Y-junctions (insert 
micrograph 3), resulting in a total of 16 serpentine incubation channels to accommodate four replicates of the four 
different reaction conditions. Finally, at the detection zone, the pitch between adjacent channels decreases such that all 
16 channels can be viewed within a microscope viewing area, thus facilitating parallel detection via microscopy (insert 








Figure 4.3. Uniformity of Droplet Bifurcation. 
 (A) In our device, microfluidic droplets split into two equal halves as they flow through a bifurcating Y-junction. To 
quantitatively analyze the bifurcation performance at the Y-junction, we measure the areas of the pair of daughter 
droplets after splitting and calculate the ratio of the area of each daughter droplet over the combined area of the two 
droplets. (B) We measured ~50% area ratio for all daughter droplets across the four bifurcation stages and the 15 Y-
junctions (n = 10 for each Y-junction), suggesting that uniform droplet bifurcation is independent of channel 








Figure 4.4 Parallelized Quadplex Injection of Reagent Droplets with Capacity for Individualized Calibration.  
(A) Parallelized injection of multiple reagents can be readily achieved in our device, as a simultaneous actuation of all 
four reagent microvalves results in four independent reagent droplets in their respective channels. (B) Variations in 
reagent inlet microvalves and differences in the viscosity of food dyes can lead to reagents droplets with different sizes. 
For example, when we injected four different colors of food dyes with an identical microvalve opening time (e.g., 30 
ms) the four resulting reagent droplets can differ by as much as 44% in normalized droplet area. (C) By adjusting the 
microvalve opening time of each individually-addressable reagent microvalve, reagent droplets with significantly 








Figure 4.5. Parallel Fusion of Sample Droplets with Reagent Droplets.  
In our device, the four split sample droplets (after two bifurcations) maintain an elongated shape as they travel past the 









Figure 4.6. Imaging-Based Parallel Detection of Fused Droplets.  
We generate multiple groups of 16 droplets (four replicates of the four sample-reagent combination) and image them at 
the detection zone via microscopy. Even droplet bifurcation, uniform reagent injection, and robust droplet fusion enable 
size uniformity for the 16 droplets. For example, the droplet sizes in group 1 and group 20 have only a standard 
deviation of 8.0% and 6.6%, respectively. Furthermore, the droplets travel at relatively the same speed through their 
own incubation channels and thus allow their spatial indices to be maintained. Indeed, for the droplets in group 1, the 
16 droplets vary by only as much as 3.69 mm in position after traveling through the 100-mm-long incubation channels, 
equivalent to a 3.69% variation. For the droplets in group 20, the 16 droplets mostly maintain their positional orders 




 A Nano Sample Processor for Genotyping 5
of Plant Samples for Marker-Assisted Selection 
Maintaining global crop production is critical to human survival. As threats to the 
global food supply continue to mount, multinational seed companies are turning to 
genomics to accelerate the rate of crop improvement. DNA marker technology offers 
great promise in plant breeding. The key to wide-spread adoption of molecular breeding 
is the availability of flexible and cost-effective tools that can perform high-throughput 
genotyping to guide the crop development process. Towards that end, we have developed 
and demonstrated a programmable droplet-based microfluidic device for genotyping of 
Maize genomic DNA. A unique component of the microfluidic platform is the Nano 
Sample Processor (NSP), which overcomes traditional limitations associated with 
microfluidic devices. The NSP is a novel architecture which is capable of introducing an 
unlimited number of plant samples onto a microfluidic device for genotyping analysis. 
 
5.1 Introduction 
In the imminent future, the agriculture industry will have to maintain the stability of 
the global food supply despite exponential population growth [144]. The complexity of 
this task will be exacerbated by the decrease of arable land, emergence of new pests, and 
abiotic stress due to changing climate patterns [145]. In anticipation of this task, there has 
recently been a global concerted effort to collect, store, and characterize crop species 
[146]. In addition, sales of genetically modified (GM) crops have increased. In GM 
crops, genes are artificially inserted using genetic engineering techniques. A panel of 
genes may be inserted or a single gene may be overexpressed. Another modern-day 
approach to developing new crops is genomic selection (GS), in which genetic 
information informs the breeding process. In GS, a large plant population is screened and 
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genetic material intrinsic to a prospective plant is used. The plant varieties developed by 
this selective breeding are referred to as cultivars. Multinational seed companies are 
increasingly turning to genomic selection (GS) to fast-track the plant breeding process 
[147] instead of spending years physically identifying plants with desired traits. By 
allowing companies to sidestep the process of growing plants in the nascent stages of 
cultivar development, GS reduces costs and accelerates the crop discovery process. 
Furthermore, GS is profoundly different from genetic engineering technologies, in that 
GS allows scientists to harness natural biodiversity as opposed to artificially introducing 
traits. The burgeoning interest in molecular plant breeding has created a significant need 
for affordable, rapid, high-throughput genotyping technologies [146]. In GS, Single 
Nucleotide Polymorphisms (SNPs) are often chosen as molecular markers because of 
their abundance throughout the genome and stability over generations [148, 149]. 
Furthermore, the bi-allelic nature of SNPs facilitates allele calling and data storage [146].   
The agriculture industry has already taken steps [150, 151] towards miniaturizing 
high-throughput genotyping. Microarrays are often used in SNP genotyping and rely on 
fixed sets of markers [152-154]. Array-based systems boast high multiplexing capacity. 
Often “universal” designs for a range of germplasms are used. To ensure applicability of 
designs across multiple species requires a large collection of SNPs, thereby increasing 
costs and the likelihood of ascertainment bias [146]. Other genotyping systems have been 
introduced to the market [138, 155-157]. Array Tape
TM
  Technology (Douglas Scientific) 
is considered state-of-the-art and is used by large multinational seed companies [146]. 
This technology processes spools of Array Tape
TM
 for assay setup, PCR, and fluorescent 
detection – genotyping up to 150,000 data points per day. Each individual reaction is 1.6 
µL, which represents a 68% volume reduction compared to standard plate-based systems, 
which use at least 5 µL reaction volumes. However, the requirement for separate modules 
for liquid handling, thermocyling and detection impedes complete automation and 
increases costs. Because these aforementioned methods do not offer flexibility and use a 
large volume, they do not meet the requirements as an affordable, flexible, genotyping 
platform for agricultural applications. 
Droplet microfluidics has the potential to satisfy the unmet needs for increased 
miniaturization, scalability and automation in genotyping. Each droplet is analogous to a 
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microcentrifuge tube and is separated by an immiscible carrier fluid, typically oil. The 




fold lower than those used in conventional 
bench-top techniques, drastically reducing cost. Droplets can be generated at kilohertz 
rates [158]. The utility of droplets has been demonstrated in applications ranging from 
single-cell [116, 159-161] and single-molecule analysis [114, 162] to particle synthesis 
[163-165]. Yet, limitations remain which prevent wide-spread adoption of droplet 
platforms, particularly for genotyping in agricultural applications. Firstly, a microfluidic 
device can at most accommodate 10-30 inlet channels due to small device footprint, thus 
limiting the number of samples that can be genotyped. The second obstacle is the ability 
(or lack thereof) of droplet devices to perform combinatorial operations. For example, 
genotyping applications require 10’s or 100’s of markers to be screened against millions 
of DNA samples. Currently, microfluidic devices excel at generating large populations of 
droplets of identical composition, but are less adept at performing the types of 
combinatorial operations that genotyping reactions require. Inherent to this concern is the 
lack of reliable fusion methods of sample droplets and reagent droplets. Several 
techniques to merge droplets have recently been proposed, including the picoinjector 
[105, 166] and electrocoalescence [167]. Electrocoalescence does not meet the 
requirements for robustness, because it requires precise synchronization of droplet 
streams. Flexibility is limited because electrocoalescence can only merge pre-formed 
droplets, and thus the ratio of the sample droplet to reagent droplets is fixed. In addition, 
both the picoinjector and electrocoalescence require optical barcodes to identify 
individual library compounds. Such barcodes place restrictions on the combinatorial 
screening power of platforms which utilize picoinjectors or electrocoalescence in droplet 
fusion modules.  
Herein, a droplet-based platform for programmable SNP genotyping in agriculture is 
presented (Figure 1A). A microfluidic chip (Supplementary Figure 1) featuring the Nano 
Sample Processor was designed to accommodate a screening assay (Invader
®
) used 
commonly in large multinational seed companies. Using this platform, we demonstrate 
multiplexed genotyping of a library of Maize samples. To the best of our knowledge, this 
is the first time that the Invader
® 
assay has been performed in a microdroplet format.  The 
Nano Sample Processor (NSP) (Figure 2B) allows for a single sample inlet to process an 
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unlimited numbers of samples. We employ a fusion method which exploits local channel 
geometry for synchronization-free injection of reagents into each sample daughter droplet 
[62]. Furthermore, droplets are indexed by their order in a 1D array, enabling the 
identification of the each droplet. Spatial indexing obviates the need for an optical 
barcoding scheme [62]. Our device operates in a continuous flow fashion: as droplets are 
being generated, droplets further downstream are simultaneously being incubated, and 
near the outlet of the device, in-line fluorescent read-out of droplets is occurring. Because 
of continuous flow operation (assembly-line), its potential throughput is higher than 
array-based systems (batch processing) because idle time is eliminated. By incorporating 
novel design aspects such as the Nano Sample Processor, traditional limitations – which 
often relegate droplet devices to the analysis of large droplet populations with identical 
composition – are overcome.  
 
5.2 Materials and Methods 
5.2.1 SNP Genotyping Workflow:  
The entire workflow is presented in Figure 1A. A short summary is presented here and 
each of the steps are discussed in more detail below. DNA was extracted from Maize leaf 
tissue or seed. DNA extraction was followed by 10-plex PCR amplification for 30 cycles. 
Following PCR-based amplification, samples were denatured to deactivate the Taq DNA 
Polymerase and snap-cooled for at least 5 minutes. Amplified Maize DNA was loaded 
onto the microfluidic device via the Nano Sample Processor (Figure 2B). DNA droplets 
(~ 5 nL) were generated and fused with SNP interrogating probes and Invader
® 
reaction 
mix (~45 nL). DNA-probe droplets were incubated for ~20 minutes at 63 °C as they 
moved throughout the incubation channel. In-line biallelic readout was performed using a 
two-color fluorescence spectroscopy detection system. Each fluorophore corresponded to 
a different allele for each SNP site interrogated. This reaction enabled coincident 
detection of two alternative alleles present at a single SNP site for a particular cultivar.  
Raw fluorescence data in both channels was APD corrected. Average droplet intensities 
of droplets were subsequently normalized. The ratio of FAM/RED signal was then used 




5.2.2 Multiplexed PCR: 
 DNA targets were extracted from 8 Maize samples. The crude DNA extracts were 
amplified using multiplexed PCR prior to the Invader
® 
assay. Reagents for the 
multiplexed PCR included FastStart Taq DNA polymerase (Roche), 10x PCR gold buffer 
with 20 mM MgCl2  (Roche), 10 mM dNTPs (Roche), and corresponding primers 
(IDT).The multiplexed PCR reaction contained 10 primer pairs. The reaction amplified 
10 multiplex loci simultaneously (Supplementary Figure 4). Reagents were heated at 95 
°C for 600 seconds and then thermocycled for 30 cycles: 95 °C for 30 seconds, 55 °C for 
90 seconds, 72 °C for 150 seconds. After thermocycling, a final extension step was 
executed at 72 °C for 300 seconds. Prior to the SNP Invader
® 
 assay, genomic DNA 
targets were denatured at 100 °C for 20 minutes, snap-cooled, and then kept on ice until 
use.  
5.2.3 Invader®  Assay Chemistry:  
The Invader
® 
Assay (Figure 1B) utilizes two simultaneous isothermal amplification 
assays in a biplex format [168]. In the primary reaction, both the Invader
® 
oligonucleotide 
and primary probe hybridize to the target of interest. An invasive structure is formed 
from the single-base overlap. This forms a 3-dimensional structure that is recognized by 
an enzyme which cleaves the 5’ Arm of the primary probe. In the secondary reaction, the 
5’ arm of the probe binds to the FRET cassette. In this secondary FRET reaction, this 
structure is recognized by an enzyme which cleaves the fluorophore and a fluorescent 
signal is generated. The combination of both reactions can provide a ~10 million fold 
signal amplification. One cost advantage of the Invader
® 
reaction is that it utilizes generic 
FRET cassettes, obviating the need for expensive TaqMan® chemistry that is customized 
for each sequence.  
 
5.2.4 Off-chip SNP Genotyping Invader® Assay (Synthetic and Genomic Targets):  
In the assay design stage, 10 polymorphic markers of interest were identified and 
selected. For markers 4, 5, 6, 7, and 9, synthetic target sets complementary to the probes 
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were manufactured by Integrated DNA Technologies (Coralville, Iowa) for initial testing. 
Each synthetic target set consisted of two oligos, “A” and “B”, one for each SNP allele. 
For all 10 markers, the Invader® probes were designed by Third Wave Technologies. 
The genomic targets consisted of DNA extracted from Maize seed. All genomic targets 
evaluated were known to be homozygous. For the genomic targets, the amplified PCR 
product (SNP) was used in the Invader
® 
Assay SNP genotyping reaction. For off-chip 
experimental results, concentrations identical to those being compared in the droplet 
format were generated in 10 µL reactions in a 96-well plate. The fluorescence from the 
96-well plate was then monitored on a CFX96 Real-Time PCR detection system (Bio-
Rad Laboratories, Inc.). Fluorescence was monitored in FAM (excitation: 450-490 nm 
and emission: 510-530 nm) and Texas Red (excitation: 560-590 nm and emission: 610-
650 nm). The Invader
® 
assay was carried out using corresponding Invader
® 
probes 
specific to the amplified targets, Cleavase XI FRET mix solution (Third Wave 
Technologies), Cleavase XI Enzyme solution (Third Wave Technologies) and MgCl2 
solution (Third Wave Technologies).  
 
5.2.5 Hydrophobic Surface Treatment of Microfluidic Device:  
To ensure the success of performing Invader® genotyping, droplets needed to flow 
smoothly throughout the device. In addition, droplet contents had to be retained from 
droplet generation to detection. This required optimization of the carrier fluid and 
modification of the surface treatment strategy. PDMS-based droplet microfluidic devices 
are conventionally treated with a hydrophobic surface treatment. Aquapel (PPG 
Industries, Pittsburgh, PA) is often used in conjunction with fluorinated carrier fluids [97, 
159, 169]. However, Aquapel treatment was observed to be incompatible with the 
Invader
® 
assay. Namely, Aquapel was found to cause the adsorption of small 
hydrophobic molecules, including FAM and Redmond Red fluorophores, out of the 
droplets and onto the PDMS side walls. These effects were more pronounced at elevated 
temperatures (~63°C), such that the DNA-Probe droplets could no longer be 
distinguished from the carrier phase (Supplementary Figure 3). Thus, the device 
fabrication was modified such that the control layer was below the fluidic channels. 
108 
 
Because PDMS is innately hydrophobic, no additional hydrophobic surface treatment 
was necessary.  
5.2.6 Optimization of Carrier Fluid, Additives, and Surfactants:  
Optimization of carrier fluid was performed for the droplet-based Invader
® 
assay. 
Different mixtures of fluorinated oils, including: FC-40, FC-3283, HFE-7500 and 
Perflurooctanol were evaluated. The addition of bovine serum albumin was found to 
improve small hydrophobic molecule (and thus fluorophore) retention within droplets. 
These results were consistent with those found in the literature [170]. However, BSA 
caused droplet sticking in the channels. A mixture of FC-40 and Perfluorooctanol (4:1 
v/v) offered the optimal balance between droplet stability and small molecule retention 
among the carrier oils and surfactants that were evaluated.  
5.2.7 On-chip SNP Genotyping Invader®  Assay (Synthetic and Genomic Targets):   
A set of solenoid valves was used to control the on/off status of the individual valves 
of the control layer on the microfluidic device. The control box was controlled by a 
MATLAB (Mathworks) program. To interface with the microfluidic device, all reagents 
were loaded into Tygon® microbore tubing (Cole-Parmer) and connected with the device 
through inlet and valve ports. Valves were pressurized at ~ 15 psi.  
Once the control layer was primed, carrier fluid was loaded onto the fluidic layer 
through the inlet. The carrier phase for our experiments consisted of FC-40 (3M) and 1H, 
1H, 2H, 2H-Perfluoro-1-octanol (Sigma Aldrich) (4:1 v/v) and was pressurized at 5 psi. 
The carrier fluid was allowed to wet the entire length of the central carrier fluid channel 
prior to droplet generation. All reagent inputs on the device were primed with the 
respective reagent. Any residual reagents in the central carrier fluid channel following 
this process were flushed out using the carrier fluid phase through the pressure relief 
channels.  
Next, the valve actuation sequence programmed in MATLAB corresponding to the 
reagent combinations to be generated on the device was executed. Pressure-relief 
channels on either side of the droplet preparation region opened during generation to 
decouple downstream fluidic resistance and droplet volume. The DNA droplet (~5 nL) 
then entered the droplet preparation region and the carrier fluid flow was halted by 
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activating an upstream valve. A mixture containing SNP-interrogating probe, enzymes, 
and FRET cassettes (~45 nL) was injected directly into the DNA-containing droplet. The 
carrier fluid valve was released, and the droplet exited the preparation region. Subsequent 
DNA-probe droplets were processed in an assembly-line process. Each DNA sample was 
screened against a library of 10 SNP-interrogating probes, resulting in a sequence 
containing 10 droplets of different probe composition per DNA sample processed. Each 
DNA-probe droplet passed through a serpentine channel to promote mixing of reagents 
prior to entering the incubation region. The incubation region was maintained at a 
constant temperature of 63°C. After incubation, in-line fluorescence readout was 
performed on droplets using dual laser spectroscopy, where fluorescence intensity data 
was collected and analyzed. 
 
5.2.8 Fluorescence Detection Setup and Data Analysis:  
Spectroscopy data was acquired using a custom-built, dual laser excitation (488 nm, 
552 nm) and dual emission channel (506-534 nm and 608-648 nm) fluorescence 
spectroscopy platform [123]. Data analysis was performed using custom scripts written in 
MATLAB [130]. The leading and falling edge of each droplet were identified as the 
location in a fluorescence data trace where the signal from the FAM dye reached three 
standard deviations about the background fluorescence of the continuous phase. 
Fluorescence data from the Red APD (Redmond Red) was analysed at each droplet 
location, as identified by the FAM signal. Integration time for photon binning was set at 
10 ms for all peak counting experiments. For each sample, four data traces were analysed 
with each trace containing at least 10 visible droplets. MATLAB was used to identify 
droplets in a data trace and generate the average intensity and standard deviations for 
each reaction condition across its repeats. The average droplet intensity each droplet was 
then used to determine the final allelic call out for that specific DNA with probe. The 
average fluorescence intensity of a DNA-probe combination droplet was divided by the 
average fluorescence intensity of a probe-only control droplet. Data was analysed 













If the FAM/RED ratio was <0.5, the call was determined to be RED. If the ratio was 
>0.5, the call was FAM. The value of 0.5 was determined as the threshold value by 
calculating the ratio of FAM/RED NTC droplets after on-chip incubation. The ratio of the 
raw fluorescence intensities of all individual 10 probes were calculated separately and 
used in normalization calculations. To easily visualize the data, the log of the FAM/RED 
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5.3.1 Droplet-Based Assay Overview:   
The purpose of this work is to adapt Maize genotyping assays, which have 
traditionally been performed in multi-well plates or ArrayTape
TM
, in a highly 
miniaturized, droplet-based format. For proof-of-concept demonstration, the isothermal 
Invader
® 
assay was chosen. The workflow of the droplet-based assay is presented in 
Figure 1. Briefly, genomic DNA extracted from Maize leaf tissue or seed, which was 
provided to us by our industrial collaborator, was amplified by PCR. PCR-amplified 
DNA samples were heated to separate double-stranded PCR products and deactivate the 
Taq DNA polymerase and then snap-cooled before they were sequentially loaded into the 
microfluidic device via the Nano Sample Processor. In parallel, up to ten distinct 
Invader
® 
reaction mix – each containing the reaction buffer, MgCl2, Cleavase, FRET 
cassettes, and a specific set of Invader® probes that target a specific SNP site of the 
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samples – were loaded into the microfluidic device via designated reagent inlets. DNA 
droplets (~ 5 nL) were generated and fused with SNP interrogating probes and Invader
® 
reaction mix (~45 nL). Fused DNA-probe droplets were incubated to perform the Invader 
reaction as they moved through the incubation channel, which was heated to 63 °C by a 
custom temperature apparatus. This reaction enabled the detection of two alternative 
alleles present at a single SNP site for a particular cultivar, with each allele corresponding 
to either a FAM-fluorophore-labelled probe or a Redmond Red (RED)-fluorophore-
labelled probe.. Immediately after Invader reaction, droplets flowed through the detection 
region, where both FAM and RED fluorescence intensities were simultaneously 
measured using a two-color fluorescence spectroscopy detection system to achieve in-
line, bi-allelic detection. After fluorescence signal processing, the ratio of FAM/RED 
signals was then used to determine the final allelic call out for that specific DNA.  
 
5.3.2 Benchtop verification of Invader assays  
The robustness of the Invader
® 
assay was first verified by detecting the alleles for all 
synthetic and genomic DNA samples in bench-top experiments. Here, reaction mixtures 
containing the reaction buffer, MgCl2, Invader® probes, Cleavase, FRET cassettes, and 
either synthetic targets or genomic targets were incubated at 63 °C for 30 minutes in a 
real-time PCR machine while FAM and Redmond Red (RED) fluorescence signals from 
these reactions were measured every 30 seconds. The results of these bench-top reactions 
served as an internal control for subsequent on-chip reactions. In addition, the bench-top 
results were cross-checked with internal data from our industrial collaborator to ensure 
accuracy.  
Synthetic targets were first detected and the method for determining the specific allele 
was established. In this work, synthetic targets are single-stranded sequences, where 
targets “A” and “B” differ by only a single nucleotide and correspond to the RED allele 
and the FAM allele, respectively. In Figure 3A, two real-time Invader
® 
amplification 
curves acquired from the pair of targets and the corresponding Invader probe set in 
Synthetic Target 4 are shown.  Here, though both curves exhibited a phase of exponential 
increase immediately after the reactions commenced, but target “A” resulted in only an 
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increase in RED fluorescence (Figure 3A, bottom) and target “B” resulted in only an 
increase in FAM fluorescence (Figure 3A, top). Both curves plateaued after 
approximately 6 minutes. The plateau indicated that the cleavage of the fluorophores 
from all FRET cassettes had been exhausted. All real-time Invader® curves for synthetic 
targets exhibited the same phase of exponential amplification followed by a plateau 
phase. The time necessary to reach steady-state fluorescence levels was incorporated into 
the microfluidic chip design, and helped determine incubation channel length. Allele call-
outs were performed by taking the ratio of the end-point intensities of the FAM to RED 
fluorescence. The value of 0.5 was determined as the threshold value by calculating the 
ratio of FAM/RED NTC. Specifically, if the FAM/RED ratio was < 0.5, the call was 
determined to be RED. If the ratio was > 0.5, the call was FAM. For Synthetic Target 4, 
target “B” indeed yielded a ratio of > 0.5, corresponding to a FAM call; target “A” indeed 
yielded a ratio of < 0.5, corresponding to a RED call.  
Figure 3B summarizes the results of the Invader
® 
assay performed off-chip for 
synthetic targets. In these reactions, Markers 4, 5, 6, 7 and 9 each had bi-allelic synthetic 
targets which differed at a single nucleotide. Each set of markers were screened against 
their respective probe. As expected, Synthetic “A” targets yielded a Redmond Red signal 
and “B” targets yielded a FAM signal. Having verified the Invader® assay in the simpler 
synthetic target case, bench-top validation of the assay using Maize genomic DNA was 
performed.  
In Figure 3C, the results of 80 separate screening reactions for the genomic Maize 
screening are shown. DNA 1-8 were each amplified using 10-plex PCR (Supplementary 
Figure 4) and then screened against each of the 10 different probes for regions of interest. 
Each Maize sample (DNA 1-8) was found to have a unique fingerprint for all 10 markers. 
To ensure that the Invader
® 
assay functioned optimally, heat denaturation of the PCR 
product and Taq polymerase was necessary prior to running the Invader
® 
 assay. If heat 




5.3.3 Sample loading into microfluidic device via Nano Sample Processor 
A novel feature of the microfluidic device is the Nano Sample Processor, which is 
designed to deliver a library of samples the microfluidic chip. Each NSP is comprised of 
an inlet channel and a rinsing channel and their designated valves. The sample loading, 
rinsing, and switching process is depicted in Figure 2B in a step-by-step manner. Briefly, 
sample 1 was loaded onto the device and was driven with compressed air. The rinsing 
valve was in the open (ON) position, allowing sample to pass through the inlet. Once 
Sample 1 was loaded into the device, both valves were closed (OFF). Droplets were then 
generated by opening the valve between the sample inlet channel and oil channel. Once 
enough sample droplets were generated, the sample inlet was closed and the rinsing valve 
was opened. Rinsing fluid was flown throughout the sample channel and followed by 
compressed air. Sample 2 was then loaded and sample droplet generation was initiated. 
Sample loading via the NSP is attractive because a large number of samples can be 
delivered to the microfluidic device without the need for additional sample inlets. 
5.3.4 Robust droplet operation and optical detection in microfluidic device  
To perform Invader® assays within droplets, the droplets needed to flow smoothly 
throughout the device. In addition, droplet contents must be retained from droplet 
generation to detection. These requirements necessitate optimization of the carrier fluid 
and modification of the surface treatment strategy. PDMS-based droplet microfluidic 
devices are conventionally treated with a hydrophobic surface treatment. Aquapel is often 
used in conjunction with fluorinated carrier fluids [97, 159, 169]. However, Aquapel 
treatment was observed to be incompatible with the Invader
® 
assay. For example, when 
we generated droplets with a bench-top reacted Invader reaction in Aquapel-treated 
devices, we observed that FAM and Redmond Red fluorophores would leak out of the 
droplets and adsorb onto PDMS side walls. These effects were even more pronounced at 
elevated temperatures (~63 °C), such that the fluorescence in droplets could no longer be 
distinguished from the background fluorescence in the carrier phase (Supplementary 
Figure 3). Thus, the device fabrication was modified such that the control layer was 
below the fluidic channels. Because PDMS is innately hydrophobic, no additional 
hydrophobic surface treatment was necessary. A mixture of FC-40 and Perfluorooctanol 
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(4:1 v/v) offered the optimal balance between droplet stability and small molecule 
retention among the carrier oils and surfactants that were evaluated. After such 
optimization, we could reliably detect bench-top reacted Invader reaction in the form of 
droplets in our device (Figure 5.3).  
5.3.5 On-Chip SNP Genotyping Invader® with Synthetic Targets  
As the first step to demonstrating the droplet-based Invader® assay, we first 
genotyped the five pairs of synthetic targets. Invader® Probes, MgCl2, Cleavase and 
FRET mix were mixed and then loaded on to the chip via a probe inlet. Target sets (“A” 
and “B”) were loaded through the two NSP inlets (Figure 2). After screening a target 
pair, another pair of synthetic targets was then loaded via the same sample inlet. Sample 
inlets were rinsed with water by opening the valve controlling the rinsing channel, 
thereby allowing water to rinse the sample inlet without proceeding further downstream 
into the chip. Synthetic target samples and reaction mix were mixed on-chip. Mixing was 
abetted by a serpentine channel region downstream from the droplet preparation region. 
After passing through the mixing region, samples were incubated at 63 °C. Droplet 
passage time through the incubation region was ~20 minutes.  
A representative recorded fluorescence trace after incubation on chip is shown in 
Figure 4A. Sequences of each pair of synthetic targets were generated in an asymmetrical 
fashion – B, B, A  – where A and B denote the Redmond Red and FAM alleles, 
respectively, for each synthetic target pair. This ensured the resulting droplets’ identities 
could be readily determined from the fluorescence data based on which synthetic target 
was generated as a duplicate. Multiple trains of droplets containing synthetic DNA were 
collected and its data corrected for APD. Figure 4A demonstrates that the sequence of 
droplets is maintained as they move from the droplet generation region towards the 
detection region. The spacing between the droplets is the carrier fluid. The height of the 
droplets is directly correlated with the droplet fluorescence intensity. For each sample-
probe combination, the droplet intensity was found to be consistent with very little 
variation. Droplet intensities of the same content were grouped using a MATLAB script.  
The resultant log of ratios of FAM signal to Redmond Red signal calculated for each 
droplet were used as an indication of the SNP allele present in the synthetic target pairs. 
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An average of all the ratios for the same set of droplets was then calculated and a final 
allele call out was determined based on this ratio. A ratio of greater than log(0.5) would 
result in a FAM call, while a ratio smaller than log(0.5) would result in a RED call. A 
comparison with the bench top data show that the on-chip Invader
® 
 assay with synthetic 
target achieved a 100% correct call out for each synthetic allele.  
5.3.6 On-Chip SNP Genotyping Invader® with Genomic Targets  
8 genomic Maize DNA samples were screened with 10 Invader
® 
probes on-chip. The 
performance of the NSP was evaluated by processing all 8 DNA samples through the 
same inlet. Specifically, the potential for cross-contamination was evaluated. 
Multiplexing was performed as described above and trains of 10 droplets (one DNA 
sample at a time with each of the 10 probes) were generated continuously.   
Because of the observed variation in fluorescence intensity based on probe, a 
ratiometric analysis was applied. The results from the on-chip multiplexed SNP 
Genotyping Invader
® 
assay with a final SNP read out for each genomic sample with each 
probe is shown in Figure 5.  A ratio > log(0.5) indicated a FAM call and similarly, a ratio 
< log(0.5) indicated a RED call. Of the 80 combinations, only one resulted in a 
mismatched call when compared to the bench top results (1.3%). However, this 
mismatched call out exhibits a log(FAM/RED) ratio very close to log(0.5), suggesting 
that additional data points for these particular cases may be necessary. Furthermore, the 
standard deviations calculated for n=3 per DNA/probe combination had low variation, 
suggesting that the signals observed and consequent allelic call outs were robust. On-chip 
collected genotypic fingerprints for all 8 Maize samples matched the bench-top reactions. 
 
5.4 Discussion 
This platform represents the first embodiment of a droplet-based, continuous flow 
platform for agricultural applications. The presented Nano Sample Processor has the 
ability to introduce an unlimited number of DNA samples on to a microfluidic device, 
overcoming limitations to the number of samples that can be introduced on to the 
microfluidic device because of small footprint. All 8 Maize genomic samples analysed 
were introduced through the same inlet, and no measurable cross-contamination was 
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observed. It is important to note that the Invader
® 
 assay can perform up to a million fold 
amplification, thus had there been any cross-contamination between successive samples, 
this would have likely been observed during detection. Therefore, the rinsing channel that 
was incorporated into the NSP was found to be highly effective in curtailing cross-
contamination between successive genomic DNA samples, and would likely to be able to 
be employed in platforms that utilize other amplification-based assays, i.e. the 
Polymerase Chain Reaction.  
By employing a valve-based reagent fusion scheme, the microfluidic device was able 
to perform combinatorial screening, which plant genotyping requires, in a flexible way 
which most microfluidic platforms cannot offer. Droplets are reliably merged without the 
need for synchronization. This device is based on valve-based droplet generation 
technology, which combines the control offered by microfluidic valves with the high-
throughput capacity of droplets. Furthermore, the device has the ability to generate as 
many DNA-probe replicates as desired.  Performing more replicates may be especially 
valuable for specific markers that are close to the threshold for allele calling. 
Simultaneous operation of droplet generation, incubation, and read-out eliminates idle 
time compared to batch-processing methods such as with the Douglas Scientific Array 
Tape
TM
. Finally, because the droplets maintain their order from droplet generation to 
read-out, the need for fluorescent barcoding is eliminated. Barcode-free continuous flow 
operation of this strategy implies unlimited potential screening capacity on a single 
device with precise composition control over the reaction content of each individual 
droplet.  
One limitation of the current platform is that there is no option to keep samples cooled 
prior to processing on-chip. Specifically, we observed that it was important for DNA to 
be denatured prior to the Invader® genotyping step to ensure accurate allele calling. 
Some of the Maize-probe combinations are near the threshold for allele calling (i.e., DNA 
2, Marker 5). It is likely this is due to partial re-hybridization of DNA prior to on-chip 
genotyping. Thus, future iterations should include a cooling element beneath the Nano 
Sample Processors to keep DNA samples in a denatured state (as a continuation of the 
snap-cooling process) prior to hybridization. In addition, the width of the cooling element 
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can be extended to be placed beneath probe inlets to preserve the integrity of Invader® 
enzymes for long operating periods.  
In future iterations of the device, the NSP design can be integrated with probe inlets in 
addition to the sample inlets, allowing probes and samples to be switched on-demand and 
enhancing flexibility in setting up screening reactions. To enhance throughput, the device 
can be coupled to a robotic sampling system [143]. Additionally, to accommodate crude 
DNA samples, a filter inlet design could be incorporated on the microfluidic device itself 
or as an adapter to the tubing that is interfaced with the device. 
This platform can potentially be adapted for many different assays. For example, the 
device can be modified such that the incubation channel loops over multiple heating 
zones for assays which require multiple temperature zones, such as the Polymerase Chain 
Reaction. In applications were droplet evaporation is a concern, our lab has developed an 
evaporation-resistant method for fabricating PDMS-based devices (unpublished work). 
We believe that the optimized surface chemistry and carrier fluid presented herein are 
applicable to a large number of assays. It is important to note that leakage of small 
hydrophobic molecules is dependent on assay chemistry and in particular, molecular 
structure and size and thus may require some fine-tuning. Herein we obtained optimal 
results by eliminating the use of Aquapel and fine tuning the carrier fluid. Another option 
is to tether small hydrophobic molecules such as fluorophores to larger molecules, such 
as antibodies, to prevent leakage out of droplets.  
Because the integrated NSP is able to introduce a virtually unlimited number of 
samples, it has the potential to replace conventionally used robotic pipetting systems or 
Array Tape
TM 
in agricultural GS applications. Additional benefits of the microfluidic 
droplet approach are the sequestration of reagents and DNA inside droplets, thereby 
minimizing cross-contamination between individual reactions. Furthermore, the cost per 
screening assay is dramatically lessened by reducing the reaction volume from 5 µL 
down to 50 nL. We believe the device presented herein has the potential to fulfil the 
unmet need for increased miniaturization, flexibility and automation in GS for cultivar 






















Figure 5.1. SNP Genotyping Workflow. 
A) SNP Genotyping Workflow. DNA was extracted from leaf tissue or seed. DNA extraction was followed by 10-plex 
PCR amplification for 30 cycles. Following PCR-based amplification, samples were snap-cooled. Amplified DNA was 
loaded onto the microfluidic device via the sample inlet. DNA droplets (~ 5 nL) were generated and fused with SNP 
interrogating probes and Invader®  reaction mix (~45 nL). DNA-probe droplets were incubated for ~ 20 minutes at 
63°C as they moved throughout the incubation channel. In-line readout was performed using a two-color fluorescence 
spectroscopy detection system. Raw data was APD corrected. Average droplet intensities of droplets were normalized. 
The ratio of FAM/RED signal was then used to determine the final allelic call out for that specific DNA with probe. B) 
Invader® Assay Chemistry: In the primary reaction, both the Invader®  oligonucleotide and primary probe hybridize to 
the target of interest. An invasive structure is formed from the single-base overlap. This forms a 3-dimensional 
structure that is recognized by an enzyme which cleaves the 5’ Arm of the primary probe. In the secondary reaction, the 
5’ arm of the probe binds to the FRET cassette. In this secondary FRET reaction, this structure is recognized by an 









Figure 5.2. Microfluidic Chip Workflow. 
A) Microfluidic Chip Workflow. Amplified DNA was loaded onto the device. Prior to the experiment, the desired 
sequence of reactions on the device was programmed. Each of the 8 DNA samples processed was screened against a 
library of 10 SNP-interrogating probes. A small amount of DNA (5 µL) was introduced into the sample inlet and 
pressurized. In the design, a novel inlet architecture was designed to accommodate a rinsing channel, thus allowing for 
an unlimited number of samples to be processed through the same inlet without measurable cross-contamination. The 
valve chopped the sample and generated a small DNA droplet (~ 5 nL). Pressure-relief channels on either side of the 
droplet preparation region opened during generation to decouple fluidic resistance and droplet volume. The DNA 
droplet then entered the droplet preparation region and the carrier fluid flow was halted by activating an upstream 
valve. A mixture containing SNP-interrogating probe, enzymes and FRET cassettes (~45 nL) was injected directly into 
the DNA-containing droplet. The carrier fluid valve was released, and the droplet exited the preparation region. 
Subsequent DNA-probe droplets were processed in an assembly-line process. Each DNA-probe droplet passed through 
a serpentine channel to promote mixing of reagents prior to entering the incubation region. The incubation region was 
maintained at a constant temperature of 63°C. After incubation, in-line fluorescence readout was performed on droplets 
using dual laser spectroscopy, where fluorescence intensity data was collected and analysed. A unique feature of the 
platform was that the programmed sequence of droplets was spatially maintained on the device – from droplet 
preparation to droplet detection – consequently, there was no need for barcoding. B) Nano Sample Processor: Sample 1 
was loaded onto the device and was driven with compressed air. The rinsing valve was in the open (ON) position, 
allowing sample to pass through the inlet. Once Sample 1 was loaded on to the device, both valves were closed (OFF). 
Droplets were then generated by opening the valve between the sample inlet channel and oil channel. Once enough 
sample droplets were generated, the sample inlet was closed and the rinsing valve was opened. Rinsing fluid was flown 
throughout the sample channel and followed by compressed air. Sample 2 was then loaded and sample droplet 











Figure 5.3 Bench-top SNP Genotyping Invader®  Assay Results.  
A) Representative curves observed from the CFX96 real-time machine. The Invader® reaction was incubated at 63°C 
and a fluorescence reading was taken every 30 seconds. Within less than 10 minutes the Invader® reaction reached a 
plateau. Allele call-outs were performed by taking the ratio of the end-point intensities of the FAM to RED 
fluorescence. If the FAM/RED ratio was <0.5, the call was determined to be RED. If the ratio was >0.5, the call was 
FAM. The value of 0.5 was determined as the threshold value by calculating the ratio of FAM/RED NTC after 
incubation. In this example, the top graph would yield a FAM call and the bottom would yield a RED call. B) Bench 
top Invader®  read out of synthetic target pairs with their corresponding probes. FAM represents the allele 
corresponding to the probe containing the FAM fluorophore (“B” target), and vice versa for RED as Redmond Red 
(“A” target). Allele call outs were correct for 100% of the cases. C) Bench top Invader®  read out of multiplexed 








Figure 5.4. Synthetic Target Results.  
A) Representative APD trace of the FAM fluorescence intensity as observed from real-time read out of the Invader®  
assay on chip using synthetic target 6. This trace contained two repeats of the same assymetrical sequence, B, B, A such 
that the first two peaks observed correspond to droplets containing the same content (synthetic target type B). The third 
droplet in the sequence contains synthetic target type A. Allele calling was performed by taking the ratio of the FAM 
intensity to the RED intensity. If the ratio was >0.5, the call was FAM. The value of 0.5 was determined as the 
threshold value by calculating the ratio of FAM/RED NTC after incubation. In this example, the first two droplets in 
the sequence would yield a FAM call and the third would yield a RED call. This matched the droplet generation 
sequence which was programmed in the MATLAB software controlling the pneumatic valves. B) Summary of 










Figure 5.5. On-chip SNP Genotyping Invader®  Assay of Genomic Targets.  
Call out chart for all 80 multiplexed reactions with 8 genomic DNA samples against 10 Invader®  probes. All Maize 
Targets 1 – 8 were screened against 10 SNP Markers. For all droplets, the FAM/RED ratio was calculated. For 
visualization, the log of the FAM/Red ratio is plotted here. Droplet sequences of 10 probes in sequential order were 
used for all genomic targets. Allele type is displayed in the chart as either green (FAM allele) or red (Redmond Red 
allele). Call out was determined by taking the average ratio of fluorescence intensities for FAM:Redmond Red, and are 
shown in the chart. Of 80 averaged reactions, only 1 resulted in a mismatched call (DNA2 with probe 5), resulting in a 




 Ultra-thin, evaporation-resistent PDMS 6
devices for absolute quantification of DNA using 
digital PCR. 
We present an array-based nanoliter digital PCR (dPCR) platform. The ultra-thin 
microfluidic device can accommodate high temperatures for extended periods, while 
minimizing evaporation. The device utilizes a very simple fabrication scheme, and can 
achieve a limit of detection of 100 attomolar of synthetic target. dPCR presents a feasible 
way to quantify rare targets, especially in high background. We demonstrate proof-of-
concept use of this device to identify methylation of synthetic DNA in high background, 
a potential biomarker for many diseases. We believe that this simple and cost-effective 




Heterogeneous diseases such as cancer are characterized by a range of genetic and 
epigenetic alterations. Traditional bulk procedures measure ensemble signals (Figure 1), 
which have very low sensitivity for infrequent sequences within biological samples. 
Sensitive detection techniques such as dPCR are required to detect rare mutations within 
a milieu of wild-type DNA molecules. However, dPCR requires extensive 
miniaturization, as thousands of parallel reactions are required per sample.  
Droplets indexed in high-density arrays enable high-throughput imaging. Different 
groups have developed dPCR systems. The “SlipChip” is one example [82], but has 
limited dynamic range due to large reaction volumes. Heyries [51] et al developed a 
megapixel digital PCR device that partitions based on surface tension. However, this 
approach requires expensive processes such as CVD. Another design includes a self-
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compartmentalization chip [85]. However, a low-permeability fluorosilane polymer was 
required to prevent evaporation, thereby raising the cost and increasing the complexity of 
fabrication.  
In this work, we have applied a unique fabrication method to build ultra-thin PDMS-
based microfluidic devices for dPCR. The method can be adopted in any laboratory and 
obviates the need for complicated processes such as CVD or spin-coating of polymers, 
thereby limiting the time and cost of fabrication, as well as making dPCR technology 
more accessible  
 
6.2 Methods 
The goals of our study were twofold: (1) to examine whether the new fabrication 
method sufficiently inhibited evaporation and permitted repeated thermal cycling and (2) 
whether dPCR could be executed on the device. Our contribution to the field of dPCR is 
the development of a fabrication method that can cheaply and rapidly produce dPCR 
devices that are resistant to evaporation. This fabrication method is described in Figure 2.  
 
6.2.1 Device fabrication 
The device consists of five layers, a break-out of which is shown in Figure 3.   One 
blank wafer is spun with 15:1 PDMS at 2100 rpm and another blank is spun with 6:1 
PDMS at 100 rpm, which serves as a temporary layer. After baking for six minutes, the 
6:1 blank layer is peeled from the wafer and placed over the 15:1 PDMS. This 
combination bakes for six more minutes to loosely bond the two PDMS layers.  The two 
bonded PDMS layers are then removed from the wafer and attached to a thin glass slide 
via O2 plasma bonding (15:1 side facing the glass).  After bonding and a five minute 
bake, the temporary PDMS layer can be peeled from the chip, leaving just the thin layer. 
A similar process is used to fabricate the thin pattern layer, using 15:1 PDMS for the 
silanized pattern wafer (900 rpm) and 6:1 PDMS for a temporary blank layer (100 rpm). 
Finally, a thin glass coverslide is plasma bonded to the top PDMS layer to reduce 
evaporation, and an adaptor placed over the inlets to interface with tubing.  
inlets and outlets of the device. The chip was placed in a vacuum chamber to evacuate 
air from the PDMS matrix and the channels within the device.  The PCR reaction mixture 
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consisted of Magic Buffer ( µl) , ROX (0.8 uL), dNTPs (10 mM, 0.8 uL), Forward and 
reverse primers (10 uM, 1.2 uL each), Platinum Taq Polymerase (0.2 uL), TAQ Probe 
(10 µM, .40 µl), DNA target (3.2 µl), 0.1% Tween-20 (2 µl), BSA (20 mg/ml, 2 µl), and 
water (24.2 µl). 1.1 g of uncured PDMS mixed at a ratio of 10:1 (base:crosslinker), and 5 
g of silicone oil (100 cst) composed the oil phase.  
 
6.2.2 Device Loading and Thermocycling 
In the first step of the workflow, sample is loaded onto the microfluidic device by 
puncturing the tape, which pulls the reagents into the wells because of the negative 
pressure inside the channels. The wells are then partitioned using the PDMS/silicone oil 
mixture, which is loaded via pressurization at 10 psi until complete. The device is 
thermocycled on a flatbed peltier for up to 60 cycles (5 minutes of 95°C, then 60 cycles 
of 15 seconds at 95°C and 60 seconds at 60°C).  
 
6.2.3 Imaging and Image Processing 
Chips are imaged on a Typhoon 9410 Variable Mode Imager at 10 µm resolution.  
Fluorescent images are obtained for both the TaqMan probe (FAM) and the reference dye 
(ROX).  Following detection, the images are imported into Matlab for processing and 
analysis.  A mask is overlaid with the image file. The resulting image contains 
fluorescent data from only the areas of interest. The central pixels of each well are used 
to measure average intensity.  Matlab’s built-in bimodal population separation function, 
multithresh, is used to set a  threshold for positive wells. Finally, the number of positive 
and negative wells are counted, and occupancy is calculated assuming a Poisson 
distribution of reaction mixture throughout the device.  
6.2.4 Evaporation 
The simple, thin-chip microfabrication technique employed reduced the evaporation 
by an order of magnitude compared to traditional microfluidic devices, which overcomes 
a critical problem for high temperature assays.  Given the same reaction conditions, an 
average of 8% evaporation can be seen per well on the thin chip. In contrast, 80% of the 
reaction evaporates after 60 cycles on a device with standard thickness. This reduction 
131 
 
allows for assays that require many cycles to be completed on the microfluidic chip.  The 
results of the comparison are shown in Figure 4.   
 
6.2.5 Digital PCR 
The microfluidic device can be used to perform digital PCR across a range of 
concentrations.  The segmentation of the reaction mixture into many wells reduces the 
background such that single events become quantifiable. We demonstrated digital PCR 
for concentrations ranging from 100 – 0.1 fM. The calculated results and expected results 
match with 14% error, as shown in Figure 5. The automatic thresholding performed by 
Matlab defines an average signal to background ratio of 10:1 across chips.  A sample raw 
image can be seen in Figure 6A.  After processing, plotting the average fluorescent 
intensity of each well produces a bimodal histogram (Figure 6B). The two populations 
are separated by Matlab’s multithresh, and the resulting number of positive and negative 
wells are counted.  The occupancy can be calculated using the equation 
 
Occupancy = Ntotal * ln (Ntotal/Nnegative ) , 
 
which assumes a Poisson distribution of positive target throughout the wells of the chip.   
 
6.3 Discussion 
The development of a robust digital PCR device meets a clinical need for detection 
and quantification of rare genetic events.  Rare mutations or allelic variations can be 
biomarkers of disease.  A device that can quantify these rare events at a digital level can 
allow for early detection of these biomarkers.  We have shown that this microfluidic 
device can quantify rare events, and performs at a robust and reproducible level.   
The implementation of such a device is limited by fabrication and usability. The 
device presented here requires only simple fabrication techniques and is facile to use. 
Minimization of evaporation is essential for running PCR on a PDMS device. This 
challenge has led most other dPCR devices to employ a complex fabrication method [2, 
3]. However, we demonstrate a technique that minimizes evaporation without any 
additional use of equipment or materials. In addition, the device presented here does not 
132 
 
require valves, which necessitate external operating equipment, but rather utilizes a single 
layer and a single inlet, minimizing the external equipment required to operate. This 
method allows wide adoption of dPCR throughout the microfluidic community. 
Further improvements to this system include increasing the limit of detection and 
multiplexing the reaction. Increasing the limit of detection can be achieved by expanding 
the grid of wells, therefore increasing the partitioning of the sample. One challenge in 
incorporating an increased number of reaction wells is the resolution of the imaging 
system. A new, ultra-high resolution imaging mechanism is required in order to increase 
well density without expanding the size of the chip beyond feasible dimensions. 
Multiplexing the reactions on the device becomes less challenging with a high-resolution 
imaging system. Without separation of targets, however, care must be taken to avoid 
nonspecific amplification. Nevertheless, this method of fabrication will drive adaptation 









Figure 6.1. Ensemble versus Digital PCR. 
In bulk experiments, rare targets will get lost in averaged signal.  In digital PCR, each original DNA molecule is 











Figure 6.2. Fabrication steps for creation of ultra-thin microfluidic dPCR chip.  
Fabrication steps for creation of an ultra-thin microfluidic dPCR chip. First, the thin layers are prepared by loose 
bonding with a sacrificial thick layer. Then, the layers are bonded via plasma treatment. After baking, the thick layer 























Figure 6.3. Device structure. 
A. Exploded view of microfluidic chip. The device has five layers: a. Tubing adaptor, b. Glass coverslip, c. Thin 










Figure 6.4. Evaporation during PCR.  
Evaporation during PCR.  Thick chips fabricated using conventional techniques experienced 80% evaporation. In 
contrast, the thin chips only experienced 8% volume loss after 60 cycles of thermal cycling (5 minutes of 95°C, then 60 











Figure 6.5. A comparison of expected and measured copies per well. 
The expected value was calculated based on the stock concentration and reaction protocol.  The measured value is 











Figure 6.6. Experimental Results.  
(A). Image of microfluidic chip from the Typhoon Scanner. The signal image (green) was obtained with 526 nm 
emission and 488 nm filter, and is overlaid with the reference image (red). After Matlab processing, average intensities 
of each well are obtained (B).  The sample result shown had an expected copy number of 0.48 and a measured copy 




 Conclusions and future work 7
 
Droplet microfluidics holds great promise as a tool in biology and medicine. The 
scope of this thesis work centered on extending the use of droplet microfluidic platforms. 
In Chapter 3, we developed a solution for performing high-throughput screening 
operations using droplet microfluidics. We expect the platform described here to be a 
promising candidate for combinatorial screening applications using droplet microfluidics. 
In Chapter 4, we further developed this technology for increased throughput. Taken 
together, we have successfully parallelized the once-serial operation in combinatorial 
droplet devices and have improved the device throughput by 16-fold. Given its current 
performance and prospect for future improvements, we believe the parallelized 
combinatorial droplet device has the potential to meet the demand as a flexible and cost-
effective tool that can perform high throughput screening applications. In Chapter 5, we 
applied this platform to an agricultural application. We believe the device presented 
herein has the potential to fulfil the unmet need for increased miniaturization, flexibility 
and automation in GS for cultivar development.  In Chapter 6 we developed a static 
droplet array for nucleic acid sensing at a single molecule level. This thesis help lay the 
groundwork for use of droplet microfluidics in applications which require combinatorial 
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Honors and Awards 
 
o Names 2015-2016 Regional Candidate for the White House Fellowship. 
o Transducer Research Foundation Travel Award (January 2014): Awarded grant ($250) to 
travel to San Francisco, USA to present research projects.  
o Graduate Student Award Travel Award (November 2013): Awarded grant ($300) to travel to 
Berlin, Germany to attend the Falling Walls Conference.  
o AT Kearney Scholarship for Falling Walls Conference, The International Conference on 
Future Breakthroughs in Science and Society (Berlin, November 2013): One out of 100 young 
researchers and entrepreneurs selected world-wide to present research in Berlin to a panel of 
“luminaries from the worlds of academia, research and business”.  
o Johns Hopkins Business and Consulting Club 2013 Case Competition (May 2013): Our team 
placed second in the JHBCC 2013 Competition out of 33 teams Hopkins-wide ($500). 
o Philanthropic Education Organization Scholar Award (April 2013): Merit-based award 
($15000) awarded to 85 women doctoral candidates selected from across the US and Canada. 
o Martin Luther King, Jr. Award for Community Service (January 2013): Nominated by the 
Incentive Mentoring Program. This year the award was presented by Benjamin Jealous, (then) 
President of NAACP. The MLK Award recognizes and encourages significant voluntary 
community by 8 faculty, staff and students at Johns Hopkins University ($200 donated to charity 
of choice).  
o Inaugural Global Young Scientists Summit in Singapore (January 20-25, 2013): Nominated 
to attend Summit (280 students selected world-wide). The program addresses the key areas of 
science & research, technology innovation & society and solutions to global challenges.  
o Baden-Württemberg Post Conference Programme for Young Scientists to the 62nd Meeting 
of Nobel Laureates in Lindau (July 07 – 11, 2012): One of 20 young researchers selected 
world-wide to attended post-conference program organized by Baden-Württemberg International. 
Program consisted of visiting various research institutions in Germany, meeting fellow 





 Lindau Meeting of Nobel Laureates in Lindau. Germany dedicated to Physics (July 1-6, 
2012): Received “Young Researcher Award” to attend Nobel Laureates meeting. One of 550 
young researchers world-wide (72 US students) selected to participate in this meeting with more 
than 25 Nobel Laureates in attendance to exchange ideas, discuss projects and build international 
networks (Sponsored by Mars, Inc).  
o MicroTas Student Travel Grant (2009): Awarded grant ($500) to travel to S. Korea to present 
research projects. 
o Medtronic Fellowship (2008): Selected from the entire incoming BME class at Johns Hopkins 
(~35 students) for fellowship ($28500) for first year of graduate school.  
o Whitaker International Fellow Scholarship (2007): Awarded grant ($28000) to complete 
Master thesis at ETH Zürich (11 fellows selected across the US).  
o Rotary International Ambassadorial Scholarship (2006): Was awarded a grant ($25000) to 
obtain a Master’s degree at ETH Zürich.  
o Rita Schaffer Undergraduate Award (2006): Recognized as student leader developing 
initiatives that strengthen my community ($400). 
 
Professional Experience 
      
o Allied Minds Fellows Program, August 2015 – Present: Research Assistant: I am involved with 
scouting, diligence, market discovery, and investment analysis for Allied Minds. Founded in 
2006, Allied Minds is a publicly-traded venture capital company (LSE: ALM, market cap 
US$1B+, 2014 FTSE 250). 
o Harvard Medical School, Center for Engineering in Medicine (PI: Mehmet Toner), April 
2006 – September 2006: Researcher: Worked with a novel microfluidic device capable of 
selective separation of rare circulating epithelial cells from whole blood samples of cancer 
patients. 
 
Journal Publications (*denotes equal contribution) 
 
1. H.C. Zec, T.H. Wang “Nanoliter array for digital methylation-specific PCR” in preparation 
2. H.C. Zec, T.D. Rane, W.C. Chu, V.W. Wang, T.H. Wang. "A microfluidic droplet platform 
for multiplexed single nucleotide polymorphism analysis of an array plant genomic DNA 
samples." in preparation 
3. T.D. Rane, H.C. Zec, T.H. Wang. “A barcode-free combinatorial screening platform for 
matrix metatalloproteinase screening”, Analytical Chemistry 2015, 87 (3), pp 1950–1956  
4. T.D. Rane, L. Chen, H.C. Zec, T.H. Wang. "Microfluidic continuous flow digital loop-
mediated isothermal amplification", Lab on a Chip 2015 Jan 22;15(3):776-82  
5. H.C. Zec, D.J. Shin, T.H. Wang “Novel droplet platforms for biomarker detection: 
implications for molecular diagnostics”, Expert Reviews for Molecular Diagnostics 
Sep;14(7):787-80  
6. T.D. Rane*, H.C. Zec*, T.H. Wang "A Serial Sample Loading System Interfacing Multiwell 
Plates with Microfluidic Devices." Journal of laboratory automation 17, no. 5 (2012): 370-
377. 
7. T.D. Rane, H.C. Zec, C. Puleo, A.P. Lee, T.H. Wang. "Droplet microfluidics for 
amplification-free genetic detection of single cells." Lab on a Chip 12, no. 18 (2012): 3341-
3347. 
8. H.C. Zec*, T.D. Rane*, T.H. Wang. "Microfluidic platform for on-demand generation of 




Peer-reviewed Conference Papers (*denotes equal contribution) 
 
1. Transducers, 2015, Alaska, USA, July ‘15: “Ultra-thin, evaporation-resistant PDMS devices 
for absolute quantification of DNA using digital PCR.” H.C. Zec, and T.H. Wang 
2. Microtas, 2014, San Antonio, Texas, USA, Oct ’14: “Continuous flow digital loop-mediated 
isothermal amplification (LAMP) in droplets.” T.D. Rane, L. Chen, H.C. Zec, and T.H. Wang 
3. Microtas, 2014, San Antonio, Texas, USA, Oct ’14: “Method for controlling water 
evaporation in PDMS-based microfluidic devices.” H.C. Zec, C.O. Keefe, and T.H. Wang 
4. H.C. Zec, T.D. Rane, P. Ma, T.H. Wang. "Parallelization of fission and fusion operations for 
high throughput generation of combinatorial droplets." In Micro Electro Mechanical Systems 
(MEMS), 2014 IEEE 27th International Conference on, pp. 334-337. IEEE, 2014. 
5. Microtas 2013, Freiburg, Germany, Oct ’13: “A Multiplexed Microfluidic Droplet Platform 
for Matrix Metalloproteinase Screening” T. Rane, H. Zec, T.H. Wang 
6. H.C. Zec, T.D. Rane, W.C. Chu, V.W. Wang, T.H. Wang. "A microfluidic droplet platform 
for multiplexed single nucleotide polymorphism analysis of an array plant genomic DNA 
samples." In Micro Electro Mechanical Systems (MEMS), 2013 IEEE 26th International 
Conference on, pp. 263-266. IEEE, 2013. 
7. H.C. Zec, T.D. Rane, W.C. Chu, T.H. Wang. "Microfluidic Combinatorial Screening 
Platform." In ASME 2012 10th International Conference on Nanochannels, Microchannels, 
and Minichannels collocated with the ASME 2012 Heat Transfer Summer Conference and 
the ASME 2012 Fluids Engineering Division Summer Meeting, pp. 91-96. American Society 
of Mechanical Engineers, 2012. 
8. IEEE 24th International Conference on Micro Electro Mechanical System, Cancun, Mexico, 
Jan ’11: “High-throughput single-cell pathogen detection on a droplet microfluidic platform” 
T.D. Rane, H. Zec, C. Puleo, A.P. Lee, T.H. Wang 
9. MicroTas 2009, Jeju, South Korea, Nov ’09 “Micro-evaporator as Interconnects tom Low-
Volume MicrofluidicComponents” H.C. Zec, C.M. Puleo, Y. Song. T.H. Wang 
10. MicroTas 2009, Jeju, South Korea, Nov ’09: “Analyte Detection in Droplets: One Molecule 
at a Time” T.D. Rane, C.M. Puleo, H. Zec, K.J. Liu, Y. Zhang, A.P. Lee, T.H. Wang 
 
Conferences / Invited Talks 
 
1. JHU CCNE Site Visit, April ’14: ““A Multiplexed Microfluidic Droplet Platform for 
Screening”  
2. JHU INBT Spring Mini-Symposium, April ’13: “A droplet platform for multiplexed single 
nucleotide polymorphism analysis."  
3. MF3 IAB Meeting, Arlington, Virginia, Dec ’10: “A programmable multiplexed microfluidic 
platform”. H. Zec, T.Rane, T.H. Wang  
4. BMES 2009 Annual Fall Scientific Meeting, Pittsburgh, PA, Oct’09: “Droplet-based micro-
evaporator for biomolecular detection” H.Zec, C. Puleo, T.H. Wang  
5. Swiss Society of Biomedical Engineering Meeting, Neuchatel, Switzerland, Sept’07: 
“Optimization of Undecalcified Bone Cryosectioning for Bone Cell Identification, Counting 
and Isolation” H.Zec, E. Waserman, R. Müller  
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6. 32nd Annual Northeast Bioengineering Conference, Lafayette College, Easton, PA, Apr’05: 
“Fixation Techniques: A Cyclic Failure Analysis”, H. Zec, D. Decoteau, D. Flannery, A. 
Hart, R. Dunn, M.D., K. Billiar, Ph.D.  
7. 31st Annual Northeast Bioengineering Conference, Stevens Institute of Technology, 
Hoboken, New Jersey, Apr’05: “A Humidifier for Olfaction Studies During Functional 




1. U.S. Patent App ‘System and Method for Screening a Library of Samples” Inventors: Jeff 
T.H. Wang, H.C. Zec, T.D.  Rane, W.C. Chu. JHU Reference Number: C11803  
2. U.S. Patent App “Parallelization of Fission and Fusion Operations for High Throughput 




Delivered guest lecture for Manufacturing Engineering 530.354 (Spring 2014)  
Teaching Assistant for ‘BioSensing and BioMEMS’ class (Spring 2014, Spring 2011): Taught 
two lab sessions and graded lab reports.  
Teaching Assistant for ‘Cell and Tissue Engineering Lab’ (Spring 2013, Spring 2012, Spring 
2011): Taught two lab sessions and graded lab reports.  
Teaching Assistant for ‘Microfabrication Lab’ (Fall 2011): Taught all lab sessions, graded all lab 
reports and homework sets.  
Teaching Assistant for ‘Modeling and Design’ (Fall 2010): Prepared lectures, graded lab reports 
and homework sets.  
 
JHU research mentor for undergraduates:  
Christopher Glover (Class of 2015, BME, University of Missouri)  
Lily Liu (Class of 2014, BME, JHU)  
Polly Ma (Class of 2016, BME, JHU) - Received Provost Undergraduate Research Award Fall 
2014. Selected for summer internship in IMEC, Belgium (2014).  
Jeffrey Knox (Class of 2014, BME, JHU)  
Melissa Gosse (Class of 2013, BME, JHU) – Selected for 2012 NNIN REU Program at ASU 
NanoFab, Arizona State University. Current position: Associate Engineer at Canon Life Sciences.  
Elmer Rho (Class of 2015, BME, JHU)  
Mackenzie Crocker (Class of 2013, Chemical and Biomolecular Engineering, JHU)  
Kutay Muslu (Class of 2014, BME, JHU)  
 
JHU research mentor for Senior Design Projects:  
Frank Qin (Class of 2012, BME, JHU) – “Microfluidic Static Droplet Arrays”. Current position: 
Technical services at EPIC.  
Joseph Choi (Class of 2012, BME, JHU) – “Microfluidic Static Droplet Arrays”. Current 
position: Masters student at JSPH.  
Thanapoom Boonipat (Class of 2011, BME, JHU) “Novel Programmable Multiplexed Droplet 
Microfluidic Device”. Current position: Medical Student, Dartmouth Medical School.  
Tae Hong Min (Class of 2010, BME, JHU).  
 
Advisor to high school undergraduate students:  
Yiyi Sun, Garrison Forest School, Women in Science in Engineering (Spring 2013)  
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Kori Davis, Dunbar High School, The Incentive Mentoring Program (Summer 2012)  
Vivian Wang, High School Student (Summer 2012) 
